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ABSTRACT 
In this thesis the maintenance of the pluripotential stem cells of the 
early mouse embryo is investigated. Differentiation Inhibiting 
Activity (DIA) is a cytokine able to prevent the differentiation of 
pluripotential embryonic stem (ES) cells in vitro when added to the 
medium in picomolar concentrations. In this study, the mRNA for 
DIA and the components of its receptor are shown, by in situ 
hybridisation, to be present in the murine blastocyst. DIA is 
expressed primarily in the trophectoderm, the first tissue to 
differentiate in the embryo, whereas the expression of its receptor is 
predominantly restricted to the inner cell mass (1CM). This suggests 
a paracrine interaction between the trophectoderm and the 1CM such 
that the differentiated trophectoderm produces DIA which binds to 
the receptors on the cells of the 1CM to maintain their pluripotential 
state. The effects of DIA on the developing embryo were 
investigated using ES cells which had been mutated to produce 
increased amounts of DIA and injected into blastocysts to generate 
chimaeras. The resulting abnormal phenotypes are consistent with 
perturbation of the stem cell pooi, and indicate that the cells in the 
early developing embryo are responsive to DIA. These results are 
considered in the light of recent findings that homozygous DIA-
deficient embryos are capable of development to term, but that 
homozygous females cannot support implantation. 
Alternative factors which may play a role in stem cell maintenance 
have been investigated. Likely candidates are interleukin-6 (IL-6), 
oncostatin M (OSM) and ciliary neurotrophic factor (CNTF), since, in 
common with DIA, their receptors utilise the signal transducing 
subunit gp130. ES cell lines could be derived with high efficiency in 
medium supplemented with IL-6 or OSM, but less effectively with 
CNTF. However, no significant expression has been seen in early 
embryos by in situ hybridisation using probes for IL-6, CNTF or CNTF 
receptor. The possible existence of another factor(s) which utilises a 
separate signal transduction pathway is considered. 
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Early Mammalian Embryology 
The entire body of a mouse is formed by a series of divisions from a 
single cell. Some of these divisions are differentiative, producing 
lineage-restricted cells. As specific tissues are formed, some cells are 
maintained in a pluripotent state. This thesis is concerned with how 
these cells are prevented from undergoing spontaneous 
differentiation, so that a pool of stem cells is available for the growth 
of the embryo and the future formation of tissues. 
All of the cells in embryos up to the 8 cell stage are totipotent, 
and can give rise to all tissues of the resulting animal when 
transferred to foster mothers alone or with the use of carrier 
blastomeres (Kelly, 1977). From the 16 cell stage the outermost cells 
of the morula begin to become committed to the trophectoderm 
lineage in response to their peripheral position (Tarkowski and 
Wroblewska, 1967). They acquire tight junctions as the embryo 
divides, and begin to pump fluid from the environment, leading to 
the formation of a cavity, the blastocoel, which characterises this 
stage as the blastocyst. A clump of undifferentiated cells remains 
attached to the trophectoderm at the polar region. These cells 
constitute the inner cell mass (1CM), and will give rise to the embryo 
proper and various extra-embryonic tissues, including the parietal 
and visceral endoderm, the visceral mesoderm, the amnion and the 
allantois over the next few days. Immediately before implantation a 
second extra-embryonic tissue, the primitive endoderm, 
differentiates on the blastocoelic surface of the 1CM. 	The 
undifferentiated cells in the embryonic region are now known as the 
primitive ectoderm or epiblast (fig. 1.1a). 
Implantation of the embryo is characterised by the initiation of 
a decidual swelling, which is produced by the uterus. This can be 
induced artificially by trauma or the administration of air or mineral 
oil to the uterus of a hormonally-responsive female mouse (Parkes, 
1929; Orsini, 1963; Finn, 1965). The deciduum persists beyond mid-
gestation, but it becomes thinner as the conceptus grows. Between 
implantation and gastrulation the structure within the deciduum is 
known as an egg cylinder. The cells of the primitive ectoderm 
remain undifferentiated until they have passed through the 
primitive streak, when they transform into mesoderm. By the end 
of gastrulation at 8.5 days post coitum (dpc) the primordial germ 
cells are the only totipotent cells remaining in the embryo, although 
many tissues possess multipotent stem cells, which generate new 
cells in a more lineage-restricted manner (fig. 1.1b). 
Prior to the completion of gastrulation the developing embryo 
possesses a considerable capacity for regulation. During 
preimplantation stages removal of blastomeres (Kelly, 1977), or the 
newly-differentiated trophectoderm (Handy side, 1978; Hogan and 
Tilly, 1978; Rossant and Tamura-Lis, 1979; Spindle, 1978; Nichols 
and Gardner, 1984) can still result in the development of a normal 
individual. A normal foetus may still develop even following 
ablation of more than 80% of the embryonic cells at the egg cylinder 
stage (Snow and Tam, 1979). The factors which govern the ability to 
regulate the overall size and maintain the appropriate proportions of 
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Fig. 1.1 	Diagrammatic representation of early mouse embryology 
Preimplantation (sizes approximately proportional) 
Postimplantation until completion of gastrulation 
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each cell type in the embryo have not yet been identified. The 
regulation of the stem cell populations is likely to be an important 
aspect of this flexibility during embryonic development. 
Grafting blastocysts, ICMs or the epiblast from egg cylinders 
under the testis or kidney capsule of adult mice can result in the 
growth of teratocarcinomas, which are tumours composed of various 
tissue types and undifferentiated malignant stem cells with an 
unlimited proliferative capacity and a tendency to metastasize 
(Stevens, 1970; Solter et al., 1970). The stem cells of these tumours 
can differentiate into a wide range of tissues when presented with 
appropriate conditions in culture (Martin et. al., 1977), or following 
injection into blastocysts (Evans, 1972; Bernstein et al., 1973; 
Brinster, 1974; Martin and Evans, 1975; Mintz and Illmensee, 1975; 
Papaioannou et al., 1975), or aggregation with morulae (Stewart, 
1982; Fuji and Martin, 1983). Such embryonal carcinoma (EC) cells 
have been derived from most inbred strains of mouse, but greater 
success has been achieved when particular strains, notably the 129 
inbred strain, are selected for the host (Damjanov et al., 1983). The 
reason for this is not entirely clear, but the increased ability to 
support teratocarcinoma formation may be connected with the high 
tendancy for 129 mice to develop spontaneous testicular tumours. 
EC cells are multipotential stem cells which will remain 
undifferentiated under certain conditions. There are several EC cell 
lines which have been used for various applications. The properties 
of the individual lines tend to vary; the most notable differences are 
the range of tissues to which each has the potential to give rise, and 
the ability or inability of each to propagate the stem cell phenotype 
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in the absence of a feeder cell layer (Martin and Evans, 1975). 
Although colonisation of most somatic tissues has been achieved with 
some EC cell lines in chimaeras, contribution to the germline has been 
reported rarely (Stewart and Mintz, 1981). 
Embryonic Stem Cells 
More recently, it has been possible to derive embryonic stem (ES) 
cells directly from blastocysts or ICMs in culture (Evans and 
Kaufman, 1981; Martin, 1981). ES cells are morphologically 
indistinguishable from EC cells in their undifferentiated state; they 
are small cells with a high nuclear to cytoplasmic ratio which grow in 
culture as compact colonies. ES cells are thought to represent the 
cells of the 1CM (Beddington and Robertson, 1987) or the primitive 
ectoderm of early embryos (Smith, 1992). ES cells have provided an 
invaluable means of studying some of the physiological, biochemical 
and genetic aspects of early embryos. The equivalent material from 
embryos in utero is relatively inaccessible and available only in 
small quantities. Within the last few years it has become possible to 
manipulate the genome of ES cells. Specific alleles can be removed or 
inactivated by means of homologous recombination (Lin et al., 1985; 
Smithies et al., 1985; Thomas and Cappecchi, 1986; 1987) and the 
resulting mutant ES cells can be injected into blastocysts to generate 
chimaeras which can then be bred to homozygosity. In this way, the 
functions of genes may be investigated by association with any 
phenotype which may arise from the ablation of individual gene 
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activity. 	Multiple mutations can be created by crossing animals 
carrying null alleles for different loci, so that genes able to 
compensate for one another may be identified, and gene interactions 
investigated. Gene trapping has recently become extensively 
employed as a means of identifying the genes important for specific 
phenomena. This technique depends upon integration into random 
genes using a visibly detectable marker and screening for expression 
patterns and phenotypes in the ES cells and the resulting chimaeras 
or their offspring (Gossler et al., 1989; Friedrich and Soriano, 1991; 
Skarnes et al., 1992). 
ES cells maintained under optimal conditions in culture have a 
cell cycle time of 18 to 24 hours (Robertson 1987). The cells in the 
1CM divide approximately every 12 hours, whereas in the epiblast 
the cells are estimated to cycle every 4 to 5 hours (Snow, 1976; 
1977; Poelman, 1980). Presumably, for incorporation into chimaeras, 
ES cells decrease the duration of their cell cycles. Several 
characteristic markers, such as SSEA-1, alkaline phosphatase and Oct 
4 are expressed by 1CM, epiblast and ES cells (Solter and Knowles, 
1978; Tam and Snow, 1981; Snow and Monk, 1983; Schöler et al., 
1990). Like the cells of the 1CM or epiblast, ES cells can give rise to 
all somatic tissues and germ cells in chimaeras when injected into 
blastocysts after many generations in vitro (Bradley et al., 1984). 
However, the ES cell lines in general use to date have been derived 
from only a few strains of mice, namely the 129 and C57B1/6 strains. 
The reason why the stem cells of other strains have proved 
somewhat resistant to propagation in culture remains obscure. 
Originally, to maintain ES cells in an undifferentiated state, it 
was necessary to grow them on a layer of feeder cells such as 
mitotically-inactivated fibroblasts (Martin and Evans, 1975). 
Subsequently, it was found that medium conditioned by Buffalo Rat 
Liver (BRL) cells obviated the requirement for the feeder layer 
(Smith and Hooper, 1987). From this conditioned medium a 
glycoprotein, differentiation inhibiting activity (DIA) was purified, 
and found to be capable of suppressing the differentiation of ES cells 
when added to the culture medium in picomolar concentrations 
(Smith et al, 1988). 
Differentiation Inhibiting Activity 
DIA is a glycoprotein of 40-45kDa, of which the core protein is 
approximately 21kDa. It is now known to be equivalent to the 
haemopoietic cytokine leukaemia inhibitory factor (LIF), a molecule 
able to induce macrophage differentiation in Ml murine myeloid 
leukaemic cells (Tomida et al., 1984). LIF has been used 
independently to maintain the pluripotential state of ES cells in 
culture (Williams et al, 1988). LIF was cloned from a T lymphocyte 
cDNA library (Gearing et al, 1987). 
DIA has many other diverse actions. It is involved in induction 
of the acute phase response of hepatocytes (Baumann and Wong, 
1989); it inhibits the differentiation of renal cells in kidney 
rudiments (Bard and Ross, 1991) and of preadipocytes (Mori et al, 
1989). It maintains viability and proliferation of haematopoietic 
progenitors (Leary et al., 1990; Fletcher et al., 1990) , primordial 
germ cells (De Felici and Dolci, 1991; Matsui et al., 1991) and sensory 
neurones (Murphy et al., 1991), while it induces the trans-
differentiation of sympathetic neurones (Yamamori et al., 1989). It 
inhibits bone resorption in foetal long bones (Lorenzo, et al., 1990), 
but stimulates bone resorption in foetal calvaria (Abe et al., 1986). 
In vivo DIA is thought to play a role in the action of osteoblasts and 
in calcium metabolism. Irradiated mice engrafted with 
haematopoietic cells producing high levels of DIA exhibit increased 
amounts of new bone formation, calcification of the heart and 
skeletal muscle and abnormalities of the pancreas, thymus, adrenal 
cortex and ovaries and cachexia (Metcalf and Gearing, 1989). 
Injection of DIA into adult mice produced various effects, depending 
upon the dose and frequency of injection. At the most severe, loss of 
body fat, thymus atrophy and behavioural differences were 
observed. The haematopoietic system was affected in several ways. 
An increase in the numbers of various haematopoietic progenitor 
cells, including megakaryocyte and platelet precursors was observed 
(Metcalf et al., 1990). A cell line, SEKI, isolated from a human 
melanoma which was associated in the patient with severe cachexia, 
was found to produce a protein identified as DIA, which was 
responsible for the cachectic condition (Mori et al., 1989). Thus, DIA 
serves many diverse functions and can act on a variety of tissue 
types. The nature of the activity of DIA in a given context is likely to 
be dictated by the target cell. DIA is known to bind to specific 
receptors which are present on responsive cells (Smith et al., 1988; 
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Williams et al., 1988; Hilton et al., 1988; Allan et al., 1990; Hilton et 
al., 1991). 
Involvement of DIA in Embryonic Development 
A factor produced by cells derived from embryos which can maintain 
stem cells in culture may be considered as a candidate for stem cell 
maintenance in embryos in vivo. To address this question, the 
expression of mRNA for DIA has been investigated in egg cylinder 
stage embryos, when totipotent stem cells are known to be abundant 
(Rathjen et. al., 1990b). Embryos of 6.5 and 7.5dpc were, therefore, 
dissected into embryonic and extra-embryonic regions to ascertain 
the presence of DIA mRNA, and its approximate localisation. This 
was performed by RNase protection, which is a very sensitive 
technique, able to detect as few as 1-2 transcripts per cell (Robertson 
et al., 1993). Sensitivity is an essential prerequisite for this 
application, since DIA is active at such low concentrations, and 
therefore, unlikely to be very abundant. The requirement for 
relatively large amounts of tissue for this procedure would demand 
prohibitively high numbers of preimplantation embryos, and it is 
primarily for this reason that the analysis has not been carried out 
on blastocysts. 
The expression of DIA mRNA has been detected in the extra-
embryonic regions of 6.5 and 7.5dpc egg cylinders (Rathjen et. al. 
1990b). There is a high proportion of differentiated tissue in the 
extra-embryonic region when compared with the embryonic part. 
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The level of expression of DIA mRNA decreases from 6.5 to 7.5dpc in 
the egg cylinder, and is negligible by 8.5dpc. This coincides with the 
depletion of the pluripotent stem cell pooi which occurs in the 
embryo over this period. The observation that DIA is expressed in 
such tissues in vivo is somewhat reminiscent of previous reports on 
ES cells grown in the absence of DIA. The characteristic 
differentiated cells in culture produce relatively high levels of DIA, 
which results in foci of ES cells retaining the stem cell phenotype 
(Rathjen et al., 1990b). At low cell density, differentiation of the ES 
cells tends to proceed to completion without added DIA. The 
differentiated cells which arise from cultures of ES cells are not, 
however, morphologically similar to the cells of the extra-embryonic 
region of the egg cylinder. 
In situ hybridisation is a technique which has been adopted for 
examining the expression of genes in various organisms, initially 
using Drosophila (Levine et. al., 1983; Akam, 1983). A labelled probe 
binds to that part of an organism in which the mRNA is being 
produced. The expression pattern of the gene thus revealed may aid 
in the elucidation of the function of the gene product. In situ 
hybridisation has been used widely in the detection of abundant 
transcripts, but to date it has been seldom applied to genes 
expressing mRNA in very small amounts. An exception to this is the 
putative signalling molecule Wnt-1, which is expressed initially at 
low levels in certain neural tissues in the presumptive brain region 
of embryos from 8.5dpc (Wilkinson et al., 1987). The levels of DIA 
transcript present in egg cylinders estimated by RNAse protections 
(Rathjen et al.1990b) are at the predicted limits of sensitivity for in 
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situ hybridisation. 	However, for specific localisation of gene 
expression and for the study of very small embryos, it is the most 
appropriate technique currently available. Here, the expression of 
mRNA for the components of the DIA system are investigated in 
early embryos. Much effort was devoted to optimising the conditions 
to create maximum visualisation of signal over the non-specific 
background. No attempt has been made here to examine the 
distribution of DIA protein on embryos. This is because sufficiently 
sensitive labelled antibodies to detect the anticipated small amounts 
of protein are not available. 
Effects of Ectopic Expression of DIA 
Over-production of DIA in the bone marrow, spleen and lymph nodes 
of adult mice has been brought about by injecting haematopoietic 
cells transfected with a retroviral construct containing DIA cDNA into 
irradiated or unirradiated mice (Metcalf and Gearing, 1989). As a 
result, these mice developed a fatal syndrome, the symptons of 
which included cachexia, excess bone formation, calcification in 
skeletal muscle and heart, and abnormalities of pancreas, thymus, 
adrenal cortex and ovarian corpora lutea. 
Some indication of the action of DIA in the embryo may be 
obtained by causing the production of DIA at inappropriately high 
levels and/or in ectopic sites during the early stages of development. 
This may be brought about by the introduction of additional DIA to 
the developing embryo in the form of ES cells which have been 
modified to produce ubiquitously relatively high levels of the 
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cytokine. Injection of these ES cells into the embryo is not carried 
out until the blastocyst stage, so the host embryo is likely to remain 
unaffected until after implantation. This means that subtle and 
specific effects can be sought in later embryos which will possess a 
wide variety of tissue types. The diffusible form of DIA is unlikely 
to be cell-autonomous. The response of the cells of the host embryo 
to the increased level of DIA may, therefore, result in an abnormal 
phenotype. This reaction may represent an amplification of the 
normal effect of DIA in the developing embryo. The interpretation of 
the phenotype of chimaeras may, therefore, provide some insight 
into the action of DIA in the unmanipulated embryo. 
Embryos Without DIA 
The requirement for the addition of DIA to ES cells in culture to 
maintain their undifferentiated phenotype, and the finding that DIA 
is expressed in a temporal and spatial pattern in the embryo 
consistent with a role in stem cell maintenance suggests that the 
removal of DIA from the environs of the embryo could seriously 
disrupt its development. Inactivation of the DIA locus in embryos 
has been accomplished in ES cells by several groups (Stewart et al., 
1991; Escary et el., 1993; Smith et al., unpublished). A replacement 
strategy was used in which homologous recombination in ES cells 
substituted exogenous DNA sequences for one of the wild type DIA 
alleles, such that a truncated form of the DIA protein was produced 
(Stewart et al., 1991), or the whole of the coding region was removed 
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(Escary et al., 1993; Smith et al., unpublished) Germline chimaeras 
were generated from these cells and the offspring bred to 
homozygosity. Surprisingly, the null homozygous embryos were 
viable, but only if they were allowed to develop in a wild type or 
heterozygous mother. In the published studies no significant 
deviation was observed from the expected proportion of homozygous 
null individuals (Stewart et al., 1991; Escary et al., 1993), but 
subsequent unpublished results exhibit a tendency for the number of 
liveborn homozygous null pups to be significantly fewer than 
anticipated (10/181 observed to date, where the expected ratio 
would be 45/181, Smith et al., unpublished) Homozygous null 
females were incapable of supporting implantation. The implication 
from these results is that embryonic expression of DIA is not 
absolutely essential for the development of the early embryo in an 
unchallenged environment. However, DIA may be necessary after 
implantation, when it may be supplied to the developing embryo by 
secretion from the uterine endometrial glands (chapter 3, and see 
below), or via transplacental delivery. The possible existence of 
another factor or factors able to maintain stem cells in the embryo, 
particularly when DIA is absent, must be considered. 
The Involvement of DIA in Implantation 
The highest expression levels of DIA detected so far are seen in the 
uterus of the adult mouse (Bhatt et al., 1991; Robertson et al., 1993). 
In one study using Northern hybridisation the level of expression 
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was undetectable in non-pregnant animals, but was found to reach a 
maximum in the uteri of pregnant females just before implantation 
(Bhatt et. al. 1991). However, significant expression has been 
detected in the uteri of non-oestrous virgin females using the 
optimised RNase protection protocol (Robertson et al., 1993). The 
mRNA has been localised by in situ hybridisation to the uterine 
endometrial glands (Bhatt et al., 1991; Smith et al., 1992). The 
function of these glands is unknown. Female mice homozygous for 
the disrupted DIA allele are unable to support implantation without 
administration of exogenous DIA (Stewart et al., 1992). DIA, 
therefore, must be essential for implantation. Transfer of wild type 
blastocysts to DIA negative mothers failed to initiate any decidual 
response in the uterus, whereas the removal of DIA negative 
blastocysts to wild type or heterozygous recipients resulted in the 
birth of viable pups, suggesting that the DIA required for 
implantation must come from the mother (Stewart et al., 1992). 
Whether the DIA produced by the endometrial glands is utilised by 
the uterus to facilitate the decidual response or by the implanting 
embryo remains unclear. 
Cytokines in Development 
Cytokines are proteins synthesised by various producer cells in 
response to inducing stimuli. They bind to the receptors on specific 
target cells. Signal transduction across the plasma membrane then 
enables the target cell to respond to the cytokine. Among the 
numerous roles of cytokines are the control of cell proliferation, 
differentiation and the resultant phenotype, processes essential 
during development. There are several classes of cytokines, defined 
broadly according to the function for which the members were 
initially identified. These classes include growth factors, 
transforming growth factors, tumour necrosis factors, interferons and 
lymphokines. DIA has been assigned to the family of colony 
stimulating factors (Clemens, 1991). Members of this class function 
mainly to regulate proliferation and differentiation of various types 
of haematopoietic cell. DIA fits into this class because of its 
characterisation as leukaemia inhibitory factor (LIF), which induces 
macrophage differentiation in Ml murine myeloid leukaemic cells 
(Gearing et al., 1987) DIA has been found to affect the 
haematopoietic system of mice when administered to mice (Metcalf 
and Gearing, 1989; Metcalf et al., 1990). Like DIA, many other 
cytokines are now known functionally to span several of the 
categories of current nomenclature. The pleiotropic nature of these 
proteins is becoming better understood now that the molecular 
structure and signal transduction pathways of their receptors are 
being unravelled. It is primarily the action of cytokines upon stem 
cell populations that has stimulated the interest here in their 




Cytokine Receptor Complexes 
The receptor for DIA belongs to the class 1 cytokine receptors, also 
refered to as the haematopoietin receptors. The main characteristics 
of this class are 
They possess no intrinsic enzymatic activities, such as kinase or 
phoshatase activity. 
They have a structure in the extracellular domain of 14 anti-
parallel 13—strands, about 200 amino acids long. These fold into 2 
barrel-like structures similar to the fibronectin type III domain 
(Patthy, 1990). 
There is a conserved pattern of 4 cysteine residues in the amino-
terminal domain. 
A characteristic motif of Trp-Ser-X-Trp-Ser (where X is any amino 
acid) is present in the carboxy-terminal domain between the 
fibronectin type III modules. Mutations in this region greatly reduce 
the binding capability of the receptor (Yawata et al., 1993). 
Other members of this class include many of the interleukins, ciliary 
neurotrophic factor, oncostatin M, erythropoietin, granulocyte 
colony-stimulating factor, growth hormone and prolactin. The 
membrane-proximal region of these receptors is recognised by 
members of the Jak-Tyk tyrosine kinase family (Stahl et al., 1994). 
The association is thought to occur in the absence of ligand, but 
kinase activation depends upon cytokine stimulation. 
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DIA Receptor 
A low affinity cell surface receptor for DIA (Kd=1-3 nM; Hilton et al., 
1991) was first isolated by expression cloning of cDNA from a human 
placental expression library in Cos cells (Gearing et al., 1991). The 
structure of this receptor is represented in fig.1.2. Its protein 
sequence is somewhat homologous to that of the signal transducer 
gpl30, previously identified as part of the receptor complex for 
interleukin-6 (11L-6; Taga et al., 1989; Hibi et al., 1991), from the Trp-
Ser-X-Trp-Ser motif of the membrane-proximal haematopoietin 
receptor domain to the C terminus. The greatest region of homology 
(65%) is seen in the transmembrane domain (Gearing et al., 1991). 
They both also exhibit the fibronectin type Ill-like conformation in 
the extracellular domain. High affinity binding (Kd= 1 0-200pM; 
Yamamoto-Yamaguchi et al., 1986; Hilton et al., 1988; Williams et al., 
1988; Rodan et al., 1990; Tomida et al., 1990), however, is brought 
about by dimerisation of the DIA-specific component with gpl30. 
A soluble form of the DIA specific subunit is known to exist which 
binds DIA with an affinity equivalent to that of the non-diffusible 
form (Gearing et al., 1991). 
Gp130 is involved in signal transduction. 	It is an essential 
component of the receptors for DIA, 1L6, ciliary neurotrophic factor 
(CNTF) and oncostatin M (OSM). Cytokines identified more recently, 
such as IL-il, are also associated with gpl30 (Yang et al., 1992; Yin 
et al., 1993). Each of the cytokines was identified independently, on 
the basis of distinct actions, but the involvement of gpl30 in their 
receptors is probably responsible for the many over-lapping actions 
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Fig. 1.2 Diagrammatic representation of some of the receptors 
utilising the signal transducer gpl30 and the current 
understanding of the operational conformation with their ligands 
DIA=differentiation inhibiting activity 
IL-6=interleukin-6 
CNTF=ciliary neurotrophic factor 
OSM=oncostatin M 
Each rectangular box represents a fibronectin type III module. 
The thin parallel lines within each signify the conserved cysteine 
residues; the thick lines indicate the position of the Trp-Ser-X-
Trp-Ser motif. 
Fig.1.2 
Composition of receptor complexes for 
DIA/LIF, IL-6, CNTF &OSM 
of these factors. Of particular interest in the context of stem cell 
maintenance in the early embryo are the recent findings that IL-6, 
CNTF and OSM are able to substitute for DIA in the inhibition of 
differentiation of established ES cells in culture (Yoshida et al., 1994; 
Conover et al., 1994; Wolf et al., 1994; Rose et al., 1994). 
Interleukin-6 and its Receptor 
IL-6 was isolated initially as a factor which stimulates B cell 
differentiation (Hirano et al., 1986). It is now known to have many 
other biological functions, including T-cell activation (Takai et al., 
1988; Uyttenhove et al., 1988), neuronal cell differentiation (Satoh et 
al., 1988; llama et al., 1989), induction of acute phase response to 
injury and inflammation (Andus et al., 1987; Gauldie et al., 1987) and 
differentiation of haematopoietic cells of the myeloid lineage 
(Liebermann et al., 1982; Shabo et al., 1988; Ishibashi et al., 1989). 
As would be predicted from the wide variety of activities of IL-6, 
this cytokine is produced by many different cell types. These 
include T lymphocytes, monocytes/macrophages, fibroblasts and 
endothelial cells (Kishimoto, 1989). The action of IL-6 on its target 
cells is brought about by homodimerisation of gpl30 in response to 
ligand binding to the IL-6-specific receptor component (Yamasaki et 
al., 1988; Taga et aL, 1989; Hibi et al., 1990). This leads to the 
activation of a receptor-coupled tyrosine kinase (Murakami et al., 
1993). A schematic representation of the IL-6 receptor complex is 
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shown in fig. 1.2. The expression patterns of the components of the 
IL-6 receptor have not yet been investigated. 
Ciliary Neurotrophic Factor and its Receptor 
CNTF was originally characterised because of its ability to support 
the survival of parasympathetic neurons from chick ciliary ganglia 
(Adler et al., 1979; Lin et al., 1989; Stöcldi et al., 1989). It has been 
attributed more recently with involvement in the survival of a wide 
range of neurons (Skaper and Varon, 1986; Blottner et al., 1998; 
Ernsberger et al., 1989; Hoffman, 1988; Arakawa et al., 1990; 
Sendtner et al., 1990; Ip et al., 1991; Oppenheim et al., 1991; 
Martinou et al., 1992; Sendtner et al., 1992). High levels of CNTF 
have been demonstrated in adult rat sciatic nerve (Stöckli et al., 
1989, 1991). More moderate expression levels of mRNA, detected by 
Northern hybridisation, were found in adult brain and muscle, and in 
the head region and skeletal muscle of 14dpc rat embryos; the 
earliest detectable CNTF mRNA is seen at 1 ldpc (Ip et al., 1993). One 
unusual feature of CNTF is the absence of a signal sequence, which 
means that the protein is confined to the cytoplasm, and is released 
only if the tissue becomes damaged. The receptor is believed to 
consist of the complex for the high affinity DIA receptor, with the 
addition of a CNTF-specific component (Ip et al., 1993; see fig.1.2). 
The CNTFRa subunit does not possess an intracytoplasmic region, but 
is bound to the cell membrane by means of a glycosy!-
phosphatidylinositol linker, which suggests that it is not involved in 
signal transduction. Transcripts for this subunit are found by 
Northern blotting of adult rat tissues to be restricted to the nervous 
system (Ip et al., 1993). In situ hybridisation to sections of rat 
embryos reveals that the expression of the CNTF-specific subunit is 
confined to presumptive neural tissues and derivatives of the neural 
crest (Ip et al., 1993). 
Oncostatin M and its Receptor 
Growth inhibition of human melanoma cells was the function which 
led to the initial identification of OSM (Zarling et al., 1986; Brown et 
al., 1987; Malik et al., 1989). Additional roles include macrophage 
differentiation of Ml cells (Horn et al., 1990) and induction of acute 
phase protein synthesis (Richards et al., 1992). So far, only a human 
form of OSM has been characterised. It is a 28kDa glycoprotein 
expressed in activated monocytic and lymphocytic cell lines and in 
normal adherent macrophages. Cloning of the murine form of OSM 
based on the available human sequence has proved difficult, 
suggesting that the homology between the two species is not great. 
Therefore, probes synthesised from the human form of OSM will not 
bind specifically to murine tissues. In situ hybridisation for OSM on 
mouse embryos will not be carried out until the murine form of OSM 
is available. 
Human OSM has been found to bind with high affinity (Kd= 10-
1000pM) to the DIA receptor complex in certain murine culture 
systems such as hepatoma and haematopoietic cells (Linsley et al., 
1989; Gearing and Bruce, 1992; Baumann et al., 1993; Gearing et al., 
1994). However, whereas DIA binds to the DIA-specific subunit, 
OSM is capable of binding only to gpl30 (Lui et al., 1992; Gearing et 
al., 1992). The gene organisation and protein structure of OSM and 
DIA are similar. Interestingly, OSM has been found to map closely to 
DIA on human chromosome 22, suggesting evolutionary linkage of 
the two cytokines (Rose and Bruce, 1991; Giovannini et al., 1993). 
There is evidence for the existence of an OSM-specific receptor 
component, since certain cell lines have been found to bind OSM with 
high affinity, whereas the binding of DIA to these is undetectable 
(Linsley et al., 1989; Gearing and Bruce, 1992). This OSM-specific 
subunit is yet to be characterised. 
ES Cells and Other Cytokines 
The signal transducing component gpl30, common to the receptor 
complexes of DIA, 11-6, CNTF, and OSM, is likely to be responsible for 
the ability of these cytokines to perform many of the same functions. 
ES cells can be maintained in culture in an undifferentiated state by 
the addition to the medium of concentrations of OSM or CNTF similar 
to those required for DIA (Conover et al., 1993). The IL-6-specific 
receptor subunit is available in a soluble form (sIL-6R), which is 
effective in IL-6 binding and induction of dimerisation of gpl30 
(Taga et al., 1989; Yasukawa et al., 1990). ES cells do not express the 
IL-6-specific receptor component (Saito et al., 1992). Therefore, sIL-
6R must be added to the culture medium in addition to the ligand in 
order that the differentiation of ES cells in culture can be inhibited 
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(Yoshida et al., 1994). OSM efficiently maintains the undifferentiated 
state of ES cells in culture. This probably occurs via the DIA receptor 
complex, since this is present on ES cells. It is not known whether 
the OSM-specific receptor component is also used in this context. 
In the viable homozygous DIA negative embryos recently 
described (Stewart et al., 1992) an alternative cytokine such as IL-6, 
CNTF or OSM may fulfil the role of differentiation suppression via the 
pathway normally invoked by DIA, since the receptor complex for 
each of these includes the signal transducer gpl30. Inhibition of 
differentiation of the stem cells in the early embryo by these other 
cytokines, as in the derivation of ES cells from blastocysts de novo, 
would provide a means of demonstrating that the early mammalian 
embryo is able to respond to cytokines other than DIA. Also, it may 
be informative to show that the embryo is able to produce these 
cytokines and their receptors. In this study, these questions are 
addressed firstly by determination of the ability of each of these 
cytokines to substitute for DIA in the derivation of ES cell lines from 
blastocysts in culture, and secondly by using in situ hybridisation to 
investigate the presence in the early embryo of transcripts of mRNA 
for these proteins. The implication that other factors exist that are 
able to substitute for the action of DIA in stem cell maintenance in 
the mammalian embryo does not necessarily mean that this role is 
not normally fulfilled by DIA. A degree of duplication of function 
may be expected in a process so crucial for mammalian development. 
Since the initiation of these studies, phenotypes for mice 
lacking IL-6 or CNTF have been established by homologous 
recombination in ES cells and breeding of the resulting chimaeras. In 
neither case was an embryonic lethal phenotype observed. For the 
ablation of IL-6, the phenotype generated in one report is 
manifested only in female mice beyond the age of reproductive 
fertility, or following ovariectomy. An increase in the level of IL-6 in 
the circulation normally arises as a result of cessation of oestrogen 
production by the ovaries. This burst of IL-6 production is thought 
to be responsible for the bone loss associated with ovariectomy or 
the menopause. 	In IL-6-deficient mice no such hormonally- 
associated bone loss occurs (Poli et al., 1994). 	Another study 
revealed that the absence of IL-6 leads to impaired immune and 
acute phase responses on exposure of homozygous null individuals to 
infection or injury (Kopf et al., 1994). CNTF-deficient mice suffer 
progressive atrophy and loss of motor neurons when adult (Masu et 
al., 1993). The fact that viable animals can develop in the absence of 
either IL-6 or CNTF suggests that neither of these cytokines can be 
wholly responsible for stem cell maintenance in the developing 
embryo. If double mutants are generated which lack both DIA and 
one or both of these other factors, the resulting phenotype may be 
more informative. Alternatively, inactivation of the receptor 
complex, particularly the common gpl30 subunit, may provide a 
means to ascertain the importance of the cytokines operating via this 
pathway in embryonic development. The possible existence of 
another means of stem cell maintenace operating in the early mouse 
embryo which utilises a different signal transduction mechanism 
may then be considered. 
In 	summary, the 	aim of this 	project is to 	investigate 	the 
expression patterns of the genes for DIA and its receptor components 
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in the early mouse embryo to establish whether these are consistent 
with the possible involvement of DIA in stem cell maintenance and 
the regulation of early embryonic development. Attempts are also 
made to determine whether DIA exerts specific effects on the cells of 
the early embryo by exposing them to DIA at inapproriate levels and 
areas, and analysing the resulting phenotypes. Finally, the possible 
involvement of other cytokines which utilise the same signal 
transduction pathway as DIA in the maintenance of stem cells in the 
early embryo is investigated. 
1 
CHAPTER 2 
MATERIALS AND METHODS 
In Situ Hybridisation 
SOURCE OF EMBRYOS FOR SECHONS 
Embryos to be used for in situ hybridisation were produced mostly 
from matings of random bred MF1 GPI-la/a mice, and occasionally 
from inbred 129 Ola or C57B1/6 strains. All mice were maintained 
on a 14 hour light / 10 hour dark regime and supplied with food and 
water ad libitum. 
Stages of embryos are represented as number of days post 
coitum (dpc), assuming fertilisation to have occurred in the middle of 
the dark period 'preceding the discovery of the vaginal copulation 
plug. Post implantation embryos from 5.5 to 8.5dpc were retained in 
the uterus, which was dissected from the animal and rinsed in 
phosphate buffered saline (PBS; Sigma) prior to overnight fixation at 
4°C in 4% paraformaldehyde (PFA; Fisons) in PBS. Pre-implantation 
embryos of up to 2.5dpc were flushed from the oviduct; 3.5dpc, 
4.5dpc and implantation-delayed embryos from the uterus, with 
phosphate buffered medium 1 (PB1; Whittingham and Wales, 1969). 
For ease of handling, all pre-implantation embryos still retaining 
their zonae pellucidae were transferred into oviducts, which were 
then rinsed in PBS, and fixed in 4% PFA. Embryos which had hatched 
from their zonae (4.5dpc and implantation-delayed blastocysts) were 
instead embedded in blocks of agarose (Flowgen) because the 
absence of the zona tended to cause them to adhere to the oviduct 
walls and become indistinguishable from the oviduct tissue in the 
sectioned material. 
EMBEDDING AND SECFION1NG 
Following over night fixation in 4% PFA specimens were rinsed in 
PBS, then 0.85% NaCl (BDH) and dehydrated through a series of 
alcohols (AnalaR, BDH), cleared in Histoclear (National Diagnostics) 
and embedded in paraffin wax (Shandon). The duration of each step 
depended upon the size of the tissue being processed, but was 
generally between 10 minutes and 1 hour. Glass slides (Chance 
Propper) were cleaned by a brief immersion in 10% HC1 (AnalaR, 
BDH) in 70% ethanol, and rinsed in water then 95% ethanol. They 
were heated to 150°C and allowed to cool before being immersed in 
4% TESPA (3-aminopropyltrioxysilane; Sigma) in acetone (AnalaR, 
BDH). They were rinsed twice in acetone, then water and allowed to 
dry at 42°C. Following this treatment they could be stored dessicated 
in the fridge for up to a month. Sections were cut at 5 or 6j.tm, placed 
on slides flooded with distilled water at 40°C and allowed to expand, 
dried overnight at 25°C, and stored dessicated at 4°C until required 
for in situ hybridisation. 
Recombinant DNA Manipulations 
cDNA Synthesis 
Total RNA prepared from adult mouse brain (kindly supplied by K. 
Lee) was used for the preparation of cDNA. First strand cDNA 
synthesis was performed by incubating 5ig of RNA with either 
500tg of a specialised primer comprising a sequence containing a 
selection of restriction enzyme sites and a string of 17 thymidine 
residues for oligo dT cDNA (Oswel DNA Services), or lOOpm4tl of 
random hexamers (Pharmacia) for random prime cDNA, in 	a 	total 
volume of 	20j.l. Each tube was incubated at 68°C for 5 minutes to 
denature the RNA, then cooled rapidly on ice for a further 5 minutes. 
To each tube was then added the following: 
0.5jil 	RNase inhibitor (Boehringer) 
4j.tl 	10mM dNTPs 
2il 	Super RT (reverse transcriptase from the exon trapping 
system of Boehringer) 
8jtl 	5xRT buffer (exon trapping system) 
4jil 	0.1M DTT (DL-dithiothreitol, Sigma) 
These tubes were then incubated at 37 °C for 80 minutes, with the 
addition of a further 2iil  of Super RT halfway through the 
incubation. The temperature was then increased to 70 °C for 10 
minutes. 60p.l of dH20 was added, giving a final volume of lOOpl. 
The cDNA was stored at -20°C. 
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Amplification of cDNA by Nested PCR 
For the first round of PCR amplification a pair of oligonucleotide 
primers (A and B) were chosen to flank a stretch of at least 300 base 
pairs of the gene, to produce ultimately an optimum length of probe 
for in situ hybridisation. Each was selected to represent 18 
nucleotides of DNA from regions of complete amino acid identity 
between the protein sequences of two different species (rat and 
human in the case of CNTFR), to have similar melting temperatures 
and to have the minimum possible amount of degeneracy (utilising 
stretches of amino acids coded for by the minimum number of 
alternative codons). The nucleotide sequence of one of these primers 
was converted to its complementary sequence so that DNA synthesis 
would be primed on both strands. For the second round of PCR 
amplification an additional 18-mer oligo primer (primer C) was 
designed to hybridise to a sequence within the first amplified 
product, but close to the 3' end of it. Second round amplification was 
carried out using primers B and C. Details of the exact sequences and 
the positions of the primers used for CNTFR are shown in chapter 4. 
Random prime and oligo dT cDNA from rat brain was used as a 
control for the operation of the primers, this being the organism 
whose sequence was used for their design. The integrity of the 
mouse cDNA was tested by performing PCR using primers which had 
been used successfully to clone metabotropic glutamate receptors 
known to be expressed in the brain from murine cDNA (gift from B. 
Pickard). A 30 cycle PCR program was designed. The mixture was 
heated to 96°C for 4 minutes to denature the template DNA, then 
cooled to 41°C for the addition of enzyme. Each tube for the reaction 
contained the following: 
1 Oj.tl 	10 x reaction buffer (Promega) 
5jil 	25mM M902 (AnalaR, BDH) 
2p.l 	lOnM dNTPs (Pharmacia) 
lp.l (500j.tg) each of oligos A and B (Oswel DNA Service) 
Spi 	cDNA 
75.5 p.1 	H20 
After thorough mixing each reaction was covered with a layer of 
mineral oil (Sigma) and the program initiated. After the hot start, 
0.5p.l of Taq DNA polymerase (Pharmacia) was added, mixed in 
thoroughly and the cycle resumed. The mixture was incubated at 
41°C for 30 seconds to allow the primers to anneal to the template 
DNA. Elongation of the sequence from the primer complementary to 
the DNA template then proceeded at 72°C for 5 minutes. After this 
time the newly synthesised sequence should have extended beyond 
the position of the other primer on the original complementary 
strand of template DNA. An increase in temperature to 93°C induced 
separation of the strands again, followed by a return to the primer 
annealing temperature, enabling the synthesis of further strands in 
the same manner. Thirty such cycles of PCR were performed to 
generate new DNA, which should consist predominantly of the 
desired sequence flanked by the two primer annealing sites. Upon 
completion of the cycle aliquots of each reaction were run on a 2% 
agarose gel to visualise any fragments which had been amplified. 
A second round of PCR amplification was performed as follows: 
5 R' of the first round PCR product was amplified with 500ig of oligos 
B and C under the same conditions as for the first round, until a 
sufficient amount of the desired fragment had been produced for 
purification by means of a Quiex kit (Quiegen). 
The purified fragment was sub-cloned into pBluescript II KS 
(Stratagene) and its identity confirmed by sequencing. The sites 
chosen were Sal 1 and Bam H 1, which are located at the 5' and 3' 
ends of the fragment. Sail and Bam H 1 sites in the polylinker 
region of Bluescript enabled the insertion of the fragment in the 
desired orientation for the subsequent production of probe template. 
PURIFICATION OF FRAGMENTS AND VECTORS 
All of the fragments produced in this study, apart from DIA-R, were 
sub-cloned into pBiuescript II KS (pBS). The reason for this is that 
pBS contains the promoters T3 and T7 located on either side of the 
multiple cloning site in opposite orientations to enable transcription 
initiation for either sense or antisense probe synthesis. The vector 
was prepared by excision of the insert from a pre-existing plasmid 
by digestion using restriction enzymes (Boehringer) which cut at 
specific sites in the polylinker region of the plasmid, corresponding 
to the sites present on the ends of the fragment. Purification of the 
vector was performed either by excising the desired band from an 
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agarose gel and extracting the DNA using a Quiex kit, or by running 
the appropriate fragment onto a piece of dialysis tubing (The 
Scientific Instrument Centre, Ltd) and recovering the DNA using the 
Elutip method (Schleicher and Schuell). For this 5-10xg of digested 
DNA were run on a 400m1 1% agarose gel at 15V overnight. A slot 
was then cut in the agarose immediately in front of the band of the 
required size and a piece of dialysis tubing, which had been prepared 
by boiling in 5mM EDTA (BDH), inserted into this. The gel was then 
run until the band adhered to the tubing. The tubing was carefully 
extracted and placed into 1-2m1 of low salt buffer for Elutip 
purification. The Elutip was washed first with 1-2m1 of high salt 
buffer, then 5m1 of low salt buffer before the DNA in low salt buffer 
was passed through it. The Elutip was washed again with 2mls of 
low salt buffer, then 0.5m1 of high salt buffer were run through and 
the solution collected in an Eppendorf tube (Sanstedt) and lml of 
ethanol added. Following ethanol precipitation for 30 minutes at 
-20°C, the DNA was pelleted by centrifugation for 10 minutes, 
washed and resuspended in 50i.tl of TE buffer. The concentration of 
the purified vector was calculated from the optical density reading 
taken by means of a spectrophotometer (Ultrospec III, Pharmacia), 
and from this the molarity could be determined. The purification of 
insert fragments was performed using the same principle. 
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LIGATIONS AND TRANSFORMATIONS 
Ligation reactions were set up with an insert to vector ratio of 1:1 by 
molarity. Separate tubes were also set up in which there was a 10 
fold excess of each. Reactions were carried out in 30jtl volumes to 
include T4 DNA ligase (0.5il; Boehringer) and 3jtl of 10 x ligation 
buffer (Boehringer). Tubes were wrapped in paper tissues, placed 
into larger tubes and incubated in the fridge overnight. This served 
to reduce the temperature of the mixture gradually to enable the 
reaction to proceed, but deterioration of the product was prevented 
by maintaining it at the reduced temperature for the rest of the 
night which was ultimately reached after the reaction was complete. 
XL1 blue competent cells (Stratagene) were used for the 
transformations, which were performed according to the following 
procedure: 
Rapidly thaw cells and place immediately on ice 
Add 15il of the ligation mixture to lOOjil of cells 
Place on ice for 10 to 30 minutes 
Heat-shock for 45 seconds at 42°C 
Return to ice for 2 minutes 
Add lml of SOB medium 
Shake at 37°C for 45 minutes 
Remove lOOiil from each tube and spread on to an Ampicillin 
plate with the addition of X gal (Sigma). Spread the remaining 
mixture on another plate 
9. After drying the plates for a few minutes, incubate at 37 °C 
overnight. 
Growth of white colonies indicated an interruption of the Lac Z gene 
in the plasmid, which suggested the occurrence of a successful 
integration event. The appearance of blue colonies implied activity 
of the intact host gene. White colonies were, therefore, picked for 
the preparation of DNA. 
SMALL SCALE PREPARATION OF PLASMID DNA 
Miniprep DNA was prepared according to the protocol described: 
Pick single colonies using a sterile Gilson tip and drop into 1 Omls 
of LB medium containing 1/1000 Ampicillin (Sigma) 
Shake bottles over night at 37°C 
Transfer 1 .5m1 to an Eppendorf tube and spin for 3 minutes 
Remove the supernatant and resuspend the pellet in 200pi  of TEN 
Add 20p.1 of phenol (Gibco BRL)/chloroform (BDH) and vortex each 
tube for 2 seconds 
Spin for 3 minutes 
Transfer the upper phase to a new tube and precipitate with 2.5 
volumes of ethanol 
After spinning for 10 minutes discard the supernatant 
Wash the pellet with 70% ethanol, dry and redissolve in 50j.tl TE 
buffer 
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Upon completion of this procedure digests using appropriate 
restriction enzymes (Boehringer) were performed to ascertain 
whether the correct insertion event had occurred. Two independent 
clones found to contain the appropriate insert were expanded by the 
following method to generate stock plasmids for future uses such as 
probe synthesis and sequencing. 
LARGE SCALE PREPARATION OF PLASMID DNA 
Dilute 2.5m1 of the original culture with 500ml of LB medium 
supplemented with Ampicillin (1/1000) in a 2 litre flask and grow 
overnight at 37 °C on an automatic shaker (New Brunswick Scientific 
Co. Inc.) 
Divide the mixture into 250m1 centrifuge bottles and spin at 
6000rpm at 4°C 
Discard the supernatant and resuspend the pellets in 25m1 TGE 
Add 5m1 of 10mg/mi lyzozyme (Sigma) in TGE and allow the 
bottles to stand for 10 minutes 
Add 60m1 of a fresh 9:1 dilution of 0.22M NaOH (BDH)/10% SDS 
(Sigma) and leave the bottles on ice for 5 minutes 
Incorporate 30m1 of 5M potassium acetate (AnalaR, BDH), pH 5, 
and leave the bottles on ice for a further 15 minutes 
Spin the bottles for 10 minutes at 6000rpm 
Filter the supernatant through gauze into a 500ml GS3 bottle 
(Sorvall) 
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Add 0.6 volume of isopropanol (BDH) and pellet the DNA by 
spinning at 8000rpm and 4°C for 10 minutes 
Remove the supernatant and take up the pellet in 8m1 of TE 
Titrate to neutrality with 3M Tris (Boehringer) and transfer to 
30m1 Corex tubes 
Add an equal volume of Tris-saturated phenol 
Spin at 8000 rpm and remove the aqueous phase to a fresh tube 
Add an equal volume of chloroform and take the aqueous phase 
into a fresh tube 
Add lml of 3M sodium acetate (AnalaR, BDH), pH 5 and 18m1 
ethanol to each tube and precipitate the DNA at -20°C for at least an 
hour 
Spin at 8000 rpm for 5 minutes at 4°C and remove the 
supernatant 
Wash the pellets twice with 70% ethanol,then dry and dissolve in 
5m1 TE 
For each tube weigh out lOg of CsC1 (Boehringer) and dissolve in 
5m1 TE 
Mix the pellet and CsC1 solution, add imi of 10mg/mi ethidium 
bromide (EtBr; Sigma) and spin down the precipitate 
Transfer the supernatant to quick-seal tubes (Beckman), balance 
using CsC1 and spin overnight at 50,000rpm (L7 Ultracentrifuge, 
Beckman), 20°C 
Fluoresce the tubes under LW UV light and withdraw the lower 
fluorescent band using a syringe and needle 
Add an equal volume of TE and extract the mixture with an 
equal volume of n-butanoi (BDH) until all traces of EtBr are removed 
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Add an equal volume of sterile water and 2 volumes of ethanol, 
mix and centrifuge at 10K for 10 minutes at 4°C 
Rinse the pellet in 70% ethanol, dry and resuspend in 500pi of TE 
PROBE SYNTHESIS 
3 5 S and 33 P (Dupont or Amersham) labelled RNA probes were 
prepared by in vitro transcription (Krieg and Melton, 1987; Rathjen 
et al., 1990a). Initially, 35 S was used for probes because it had been 
found by other workers to provide satisfactory results. Less was 
known about the merits of 33 P in the context of in situ hybridisation 
at that time. 33 P is more expensive, but it is required in smaller 
amounts for probe synthesis than is 35 S. Also, using 35 S DTT must 
be present throughout the reaction to prevent the formation of 
disuiphide bonds which will interfere with hybridisation. This is not 
necessary when making probes using 33 P, which has the advantage 
of reducing the number of ingredients in the protocol and also 
reducing the cost to counter-act somewhat the higher price of 33 P 
compared with 35•  However, the primary advantage of 33 P is the 
considerable reduction in exposure time in this context from 6 weeks 
for 35s  to 10 days. Both forms of radioactive label can be stored 
prior to use for 4 to 6 weeks. Probes were synthesised by mixing 
together the following ingredients at room temperature: 
2 n g 	Template DNA 
0.75j.tl 	200mM DTT (for 35 S labelled probes) 
I. , 
0.75p.1 2mg/mi bovine serum albumen (BSA; Sigma) 
2.25 jil mixture of equal volumes of 0.5mM adenine, guanine and 
uridine for 35 S, or adenine, guanine and cytidine 
(Boehringer) for 33 
0.5 .tl 	RNase inhibitor (B oehringer) 
6.25p.l 	CTP 35 S labelled (1000-1500 Ci/mM), or UTP 33 P 
labelled (2000 Ci/mM) 
10 x transcription buffer 
lj.tl 	polymerase, either Ti, T3 or SP6 (Boehringer) 
The reaction was incubated at 37°C for 1 hour, after which 2pi of 
RNase-free DNase (Boehringer) were added and the incubation 
continued for a further 20 minutes. Probes were made up to lOOp.l 
by the addition of 85jil of dH20, phenol/chloroform extracted and 
separated from unincorporated nucleotides by centrifugation through 
a column of sephadex G-25 (Pharmacia) in a lml syringe. 
Incorporation of radioactivity was measured using a liquid 
scintillation analyzer (1600CA Tricarb, Canberra Packard), and the 
size distribution estimated by running on a 4-6% acrylamide 
(National Diagnostics) denaturing gel. Satisfactory probes were 
stored at -80°C for up to a month. 
PREPARATION OF SECTIONS FOR HYBRIDISATION 
Pretreatment of sections 	was 	carried 	out according to 	a modified 
form of the protocol devised by Wilkinson and Green, (1990). 	Slides 
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were passaged through histological 	staining dishes (Raymond Lamb) 
containing the following solutions at room temperature: 
xylene (BDH) 2 X 10 minutes 
100% ethanol 2 X 2 minutes 
90, 80, 70, 50, 30% ethanol 2 minutes each 
0.85% NaCl 5 minutes 
PBS 5 minutes 
4% PFA in PBS 20 minutes 
PBS 2 x 5 minutes 
20p.g/ml proteinase K 7.5 minutes 
(Sigma) in 50mM Tris, 
5mM EDTA (on slides 
laid 	horizontally) 
PBS 5 minutes 
4% PFA in PBS 5 minutes 
sterile dH20 10 seconds 
0.1M Triethanolamine 30 seconds 
(TEA; Sigma), pH 8 
0.1M 	TEA + 625R' 10 minutes 
acetic anhydride (BDH) 
PBS 5 minutes 
0.85% NaCl 5 minutes 
30, 50, 70, 80, 90% ethanol 1 minute each 
100% ethanol 3 x 5 minutes 
Slides were air dried for a few hours prior to the prehybridisation 
step. 
Prehybridisation was carried out at 55°C in plastic copling jars 
(Raymond Lamb) for 2 hours. The prehybridisation mix contained 
the following: 
25m1 	deionised formamide (IBI) 




Sm! 	0.1M sodium phosphate (BDH) 
2.5m1 	10mg/mi Yeast RNA (Boehringer) 
1 Oml 	50% dextran sulphate (Phármacia) 
This step was introduced to reduce non-specific binding of the probe 
to the tissue. Probe was then added to lml of the hybridisation mix 
to an approximate concentration of 1 x 10 5 dpmlp.l, DTT was added 
to 50mM in the case of 3 5 S labelled probes, and the mix applied to 
the slides from which the pre-hybridisation solution had been 
drained. Hybridisation was allowed to proceed overnight in sealed 
containers, humidified with 50% formamide at 55°C. The probe was 
retained on the sections by means of clean glass coverslips. After 
hybridisation, the coverslips were removed by a 15 to 20 minute 
incubation in 5 x SSC, (including 10mM DTT for 35 S labelled probes). 
Post-hybridisation washing was carried out: 
LLL 
50% formamide, 2 x SSC, (0.1M DTT) 1.5 hours 70°C 
NTE buffer 3 x 10 minutes 37°C 
NTE + 40ug/ml RNase 30 minutes 37°C 
NTE 15 minutes 37°C 
50% formaniide, 2 x SSC, (0.1M DTT) 1 hour 70°C 
2xSSC 3 x 10 minutes RI 
0.1 x SSC 	 3 x 10 minutes RI 
30, 50, 70, 90% ethanol in 
03M ammonium acetate (AnalaR, BDH) 1 minute each RI 
100% ethanol 	 2 x 5 minutes RI 
Air dry 
(DTT is required only for 35 S labelled probes) 
AUTORADIOGRAPHY 
Procedures were carried out in a dark room under a safe light (Ilford 
914). Approximately lOmis of emulsion (Ilford KS) were melted in a 
water bath at 40°C and mixed with an equal volume of water 
containing a drop of glycerol (AnalaR, BDH) to prevent shearing of 
the emulsion. Slides were coated by plunging them in pairs, back to 
back, into a slide dipper (custom-made by G. Robertson) containing 
the molten emulsion mix. They were allowed to drain before being 
placed into a light-tight box containing silica gel (BDH) at room 
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temperature to dry over night. They were then transferred to a 
sealed slide box with silica gel, wrapped in foil, and stored at 4°C for 
the desired exposure time, usually 6 weeks for 35 S or 10 days for 
3 3 P. Slides were allowed to warm up to room temperature, 
developed by immersing in D19 developer (Kodak) for 4 minutes, 
rinsing in water and fixing in a 1:3 mix of Kodafix (Kodak) in distilled 
water for 4 minutes, all at room temperature. After extensive 
rinsing in water, the slides were stained with 0.1% methyl green 
(Gurr, BDH), rinsed, dried and mounted in DPX (Gurr, BDH). 
Observation and photography could then be carried out at leisure 
after the mountant had set. 
OBSERVATION AND PHOTOGRAPHY OF RESULTS 
A Vanox microscope (Olympus) was used for all detailed observation 
and photography of sections. For preimplantation embryos, a x60 oil 
immersion objective was employed. Other specimens were generally 
studied using x4, xlO, x20 or x40 dry objectives. 
ES Cell Culture Medium 
UHP water 	 170m1 
10 x GMEM (Gibco) 	 20m1 
Sodium bicarbonate 	 6.6m1 
(7.5% stock, Gibco) 
Non-essential Amino Acids 	 2m1 
(100 x stock, Gibco) 
Glutamine+S odium Pyruvate 	 4m1 
(200mM+lOOmM stock, Gibco) 
Mercaptoethanol (Sigma) 	 200jil 
Foetal Calf Serum (FCS; Gibco) 	to 10% 
Factor (eg DIA) 	 as required 
ES Cell Derivation Medium 
As for ES cell culture medium, but with 15% FCS 
GPI Isomerase Electrophoresis 
Tris Glycine Buffer (p118.1-8.5) 
Tris 	 3g 
Glycine (Gibco) 	 14.4g 
dH20 	 1 litre 
1 
Tris Citrate Buffer (p H 8.0) 
Tris 	 20.lg 
Citric acid (Sigma) 	 8g 
dH2O 	 500m1 
Stain 
Fructose- 6-phosphate (Sigma) 	 20mg 
NADP (Nicotinamide adenine 	 2.7mg 
dinucleotide phosphate, Sigma) 
NBT (Nitroblue Tetrazolium, Sigma) 	2.7mg 
Glucose- 6-phosphate dehydrogenase 	1 Op.! 
(Sigma) 
PMS (Phenazine methosuiphate, Sigma) 	30p.l of 10mg/rn! 
stock 
Make up fresh, protect from light. 
LB Medium 
Tryptone (Difco) 	 1 Og/l 
Yeast (Difco) 	 5g11 
NaCl 	 5g11 
MgC1.6H20 (BDH) 	 2g/! 
dH20 	 1 litre 
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Na2PO4 (Sigma) 0.300 
KH2PO4(BDH) 0.020 
Glucose (Sigma) 0.104 
Sodium pyruvate (Gibco) 0.0045 
Penicillin (Sigma) 0.0062 
CaC12 (BDH) 14mg 
M902 (Sigma) 10mg 
1% phenol red (Sigma) 0.1ml 
UTP H20 to lOOmis 
Foetal calf serum 	 10% 






Yeast Extract (Difco) 
	
5g/1 
NaCl 	 0.5g/l 
Autoclave 
Before use, add lml of filter sterilised MgC1/MgSO4 (BDH) 





tn-sodium citrate (BDH) 	 441 g 
dH20 	 to 5 litres 








0.5M TnisHCl, pH 7.5 
1mM EDTA, pH 8.0 
TBE Buffer 
Tris 	 15g 
Boric acid (AnalaR, BDH) 	 2.5g 
EDTAINa 	 ig 
dH20 	 1 litre 
TE Buffer 
TrisHCl, p117.5 	 10mM 
EDTA/Na, pH8 	 1mM 
TEN Buffer 
TrisilCi, pH8.0 	 0.1M 
EDTA, p118.0 	 0.O1M 
NaCl 	 1M 
TGE Buffer 
Glucose 	 50mM 
TrIsHC1, pH8 	 25mM 
EDTAINa, pH8 	 10mM 
in dH2O 
CA 





















































Phosphate buffer, pH7.3 
MgC12 
sodium desoxycholate (Sigma) 
NP40 (Nonidet 40, Sigma) 























IN SITU HYBRIDISATION ANALYSIS OF THE EXPRESSION OF DIA 
AND ITS RECEPTOR IN THE EARLY MOUSE EMBRYO 
Introduction 
DIA is a pleiotropic cytokine which is able to maintain embryonic 
stem (ES) cells in an undifferentiated state when added to the 
culture medium in picomolar concentrations (Smith et al., 1988). 
It can act on the stem cells in the blastocyst when put into culture, 
enabling the establishment of ES cell lines (Nichols et al., 1990; 
Pease et al., 1990). DIA may, therefore, be considered as a 
candidate molecule for maintenance of the stem cells required 
during early embryogenesis in vivo. Transcripts for DIA mRNA 
have been detected in mouse blastocysts by RT-PCR (Conquet and 
Brillet, 1990, Murray et. al., 1990). Preliminary analysis by in situ 
hybridisation and RT-PCR has suggested that DIA is expressed in 
the egg cylinder, where there is known to be a residual core of 
pluripotential stem cells (Conquet and Brillet, 1990). DIA mRNA 
has also been detected in the egg cylinder by RNase protection, 
particularly in the extra-embryonic region (Rathjen et. al., 1990b). 
The levels of transcript estimated by this technique are extremely 
low, representing less than 10 copies per cell. 
There are known to be two forms of DIA (Rathjen et. al. 
1990a). One is diffusible (DIA-D), the other is associated with the 
extracellular matrix (DIA-M). The two forms of transcript differ 
at the 5' end as a result of alternative promoter and first exon 
usage (Fig. 3.1). This results in the transcript for DIA-D possessing 
a unique sequence of about 150 nucleotides at the 5' end, whereas 
the DIA-M-specific sequence is only about 50 nucleotides long. It 
has been possible by RNase protection to distinguish both forms of 
DIA, but for sufficient sensitivity using the in situ hybridisation 
technique, a sequence longer than 50 nucleotides is desirable. It 
is for this reason that a probe specific for only the D-form has 
been generated in the present case. 
In situ hybridisation has been carried out here using a 
probe for DIA which will hybridise to both the D- and M- form, a 
probe specific for the D- form, and probes for the DIA receptor 
subunit (DIA-R) and the signal transducer gpl30. The embryonic 
stages selected were morulae, blastocysts of 3.5dpc, pen- and 
delayed implantation, and postimplantation embryos of 5.5 to 
8.5dpc. Pluripotential stem cells are abundant until 7.5dpc, but 
are gone by 8.5dpc, when gastrulation is complete. Because of the 
very low levels of transcript previously documented for DIA in 
the embryo, it is possible that in situ hybridisation may fail to 
detect areas of expression. Optimisation of the protocol has been 
carried out to achieve maximal signal over background, but this 
technique still remains less sensitive than RNase protection 
analysis. However, it provides a means of detecting more 
specifically the localisation of the signal and may be used to 
investigate the expression patterns of preimplantation embryos, 
where the small size restricts the availability of tissue. Because 
the low levels of mRNA are likely to result in translation of only 
small amounts of protein, detection of the DIA protein using 
Fig. 3.1 	Diagrammatic representation of the DIA gene showing 
the regions recognised by the probes used for in situ 
hybridisation. 
UTR=untranslated region 
D=promoter and first exon specifying the diffusible form of DIA 
M=alternative promoter and first exon specifying the matrix-
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labelled antibodies is likely to be equivocal, unless such antibodies 
are very sensitive. Tracing the distribution of DIA and its 
receptor by this means has not been attempted here, since 
sufficiently sensitive antibodies were not available for this study. 
A series of in situ hybridisations has been compiled to determine 
the onset of expression of the mRNAs for DIA and its receptor, and 
to establish whether their patterns of expression are compatible 
with the proposal that DIA plays a role in the development of the 
early mammalian embryo. - 
Materials and Methods 
Embryos and uterine samples were obtained generally from mice 
of the MF1 (albino) outbred strain, 	and 	occasionally from the 
inbred 129 or C57131/6 strains. They were processed as described 
in chapter 2, sectioned at 5 or 6pm and taken through the in situ 
hybridisation protocol of chapter 	2. Probes were designed and 
constructed as follows: 
DIA (both D- and M- forms) 
The plasmid pDR1 contains a 650bp EcoRl insert spanning the 
whole of the coding region of the murine DIA cDNA in pBluescript 
II KS (Rathjen et al., 1990a; fig 3.2a). A template for the anti-
sense probe was made by linearising this plasmid by digestion 
with HinDlil; the sense control template was produced by 
digestion with BamHl. Radioactively-labelled RNA probes were 
synthesised as described in chapter 2. For the anti-sense probe 
transcription 	was initiated from the T7 promotor; synthesis from 
the T3 promoter was adopted for the sense control (fig 	3.2a). 
DIA-D (specific for the diffusible form) 
The sequence specifying the alternative first exon which leads to 
the transcription of the mRNA specific for the diffusible form of 
DIA was excised from the above plasmid by digestion with Eael 
Fig. 	3.2 Diagrammatic representation of the plasmids used for 
synthesis of radioactively-labelled probes for in situ 	hybridisation 
An anti-sense probe for the whole coding region of the DIA 
gene (650bp), recognising mRNA for both the diffusible and 
matrix-associated form of DIA is generated by linearisation with 
HinD!!! and transcription from the T7 promoter; the sense control 
probe is initiated from T3 after linearisation with BamHl. 
A probe to recognise only the diffusible form of DIA mRNA 
(163bp) is created by linearisation using HinD!!! and transcription 
from the 17 promoter. 
C. 	Linearisation using Xbal and transcription from the SP6 
promoter generates a probe of 980bp which recognises the extra-
cellular domain of the DIA-specific component of DIA receptor 
(D!A-R, see fig. 1.2). 
d. 	Two probes for gpl30 have been used. A short probe (330bp) 
recognising the transmembrane domain (see fig. 	1.2) is 	made by 
digestion of the plasmid using BamHl and transcription from the 
17 promoter. The longer probe (2980bp), recognising the whole 
of the coding region for gpl30 arises from linearisation using 
Xbal and transcription from the T7 promoter. 
Fig. 3.2 
HinDlil 
HinDu 	cR1 	 b 	
Xhol\ 
 1EcoR1 ae1/Not1 
DIA cDNA (650bp) 	 DIA-D exon (163bp)
Rl 
amHl 
T7 	 pDIA-D (In PBS) 
pDRI (In pBS) 
	 3.10 Kb 
3500 bp 
C 
Xba1amH1 	 d 
DIA-R (980bp) 
pLV 980 (In pGEM 2) 
3.90 Kb 	 SP6 
  
Xhol EcoRl 	" 
I Aft 
and Xhol. Double digestion produced 6 fragments, from which the 
desired fragment of 163bp was excised from an agarose gel and 
purified by means of the Elutip method (see chapter 2). This was 
sub-cloned into pBluescript at sites in the polylinker produced by 
digestion with Xhol and Noti by the method described in chapter 
2. This plasmid is now known as pDIA-D (fig. 3.2b). It was 
linearised using HinDill and the labelled antisense probe 
synthesised as described using T7 RNA polymerase. 
DIA Receptor 
The probe for in situ hybridisation for the muriñe DIA receptor 
was prepared from plasmid pLV980 (see chapter 2). This plasmid 
contains a 980bp fragment of DIA-R cDNA cloned by PCR 
amplification of adult mouse liver cDNA, using oligonucleotide 
pairs to correspond to amino acids 196 to 201 and 509 to 514 of 
the published mouse soluble DIA-R protein sequence (Gearing et 
al., 1991; I. Chambers, unpublished). The fragment was cloned 
into pGEM-2. The probe for in situ hybridisation is directed at the 
region of the gene coding for the extracellular part of the protein, 
and should, therefore, detect transcripts encoding both the 
transmembrane and soluble forms of the receptor (I. Chambers, 
unpublished). The plasmid was linearised using Xbal, and 
synthesis initiated using SP6 RNA polymerase (fig. 3.2c). 
a' 
Gp130 
A murine gp130 cDNA was provided by T. Taga (Osaka). This is a 
2.9kb EcoRl fragment in pBluescript SK. Two probes were 
generated for in situ hybridisation. One was directed at a short 
region of the cytoplasmic domain. This probe was generated by 
digestion of the plasmid with BamHl and gel purification of the 
4kb band, representing the linearised plasmid from which 1.8kb 
of the gpl30 sequence had been excised (fig. 3.2d). Transcription 
from the T7 promoter produces a sequence of 330bp; this was 
radioactively-labelled for use as a probe for in situ hybridisation 
(see chapter 2). The other probe included the full length coding 
region (2.9kb), and was made after linearising the plasmid with 
Xbal and transcribing from the T7 promoter (fig. 3.2d). After 
labelling, the probe was hydrolysed to generate smaller lengths of 
RNA of around 200bp, which are thought to penetrate the tissue 
more efficiently (Wilkinson and Green, 1990). Hydrolysis was 
performed by incubating the probe for 75 minutes with equal 
volumes of 80mM NaHCO3 and 120mM Na2CO3, followed by 
purification through a Sephadex G-50 column. 
The specificity of the probes could be ascertained by testing 
their ability to hybridise specifically on a Southern or Northern 
blot from murine tissues to a band or bands which could be 
identified as transcripts from the gene under investigation. The 
absence of additional bands indicated that the probe wOuld not 




Specific deposits of silver grains can be detected by the blastocyst 
stage at 3.5dpc. The distribution of grains indicates differential 
expression of the mRNAs. Using the probe for DIA, the signal is 
apparently restricted to the trophectoderm (fig. 3.3a). Of 24 
blastocysts observed during successful runs of the in situ protocol 
(when specific signal was detected on the endometrial gland 
controls, see below), 23 exhibited specific localisation of grains 
over the trophectoderm region. The probe for D-DIA exhibited a 
less dense distribution of silver grains when used on blastocysts, 
compared with that obtained using the full length probe for DIA. 
However, in experiments when D-DIA and full length DIA were 
used on blastocysts during the same run, the level of expression 
detected with the full length DIA probe was lower than had been 
observed on previous occasions. The reason for this variability 
between runs of in situ hybridisation is not clear, since volumes of 
probe were added to each hybridisation to provide equivalent 
numbers of counts per minute, and, as far as possible, the other 
conditions during the procedure were standardised. Localisation 
of signal to the trophectoderm region could be clearly seen in 
blastocysts of 4.5dpc and in delayed implantation using both the 
full length DIA probe and the probe specific for the diffusible 
form (figs. 3.4b and 3.5b). 
I ••L 
Fig. 3.3 In situ hybridisation on sections of 3.5dpc blastocysts 
(x60 oil immersion). 
The probe for the whole of the coding region for the DIA gene 
can be seen to hybridise to cells of the trophectoderm. 
Hybridisation using the DIA-R probe is predominantly confined 
to the inner cell mass (1CM). 
C. The probe for gpl30 can be seen to hybridise to the whole 
blastocyst, but a greater concentration of grains is seen over the 
1CM. 
I I. 
Fig. 3.3 	a 
	





























On blastocysts exposed to probes for the DIA-specific 
receptor subunit (DIA-R) and gp130 the grains are predominantly 
located over the 1CM (figs. 3.3b and c). In addition, there does 
appear to be some gp130 mRNA in the trophectoderm (fig. 3.3c). 
For DIA-R, 26 out of 30 blastocysts examined displayed a higher 
concentration of signal over the 1CM. In the case of gpl30, 30 out 
of 33 blastocysts bore deposits of silver grains, but because gpl30 
is probably ubiquitously expressed, specific signal is not always 
distinguishable from non-specific binding. However, such a 
concentration of grains over the tissue was not seen using sense 
control probes for DIA. Similar patterns of distribution are seen 
on both the 4.5dpc pen-implantation (figs. - 3.5c and d) and 
implantation-delayed blastocysts (figs. 3.4c and d). 
Implantation delayed blastocysts can be held at the same 
stage for many days (Bergstrom 1978). In this study, embryos 
were delayed for 4 days. To achieve embryonic diapause, the 
source of oestrogen is removed by ovariectomy. Hatching from 
the zona pellucida occurs, but giant cell transformation is 
prevented and differentiation of the primitive endoderm is 
reduced (McLaren, 1968; Van Blerkom et al., 1979; Given and 
Weitlauf, 1981). In situ hybridisation on delayed blastocysts 
using probes for DIA and its receptor complex has produced a 
similar picture to that seen with non-delayed blastocysts (fig. 3.5 
vs fig. 3.3 and 3.4). This persistence of the expression patterns 
establishes that the transcription of DIA and its receptor complex 
is maintained during delay. Therefore, the expression of these 
I- L. 
Fig. 3.4 In situ hybridisation on sections of blastocysts in 
implantation delay (x60 oil immersion). 
The probe for DIA hybridises to the trophectoderm. 
mRNA for the diffusible 	form 	of 	DIA 	is 	produced 
predominantly in the trophectoderm. 
DIA-R nIRNA is predominantly localised to the 1CM. 
The probe for gp130 mRNA hybridises to the whole blastocyst, 











genes in the early embryo is unlikely to represent a simple 
response to the maternal hormone oestrogen. 
Unequivocal deposits of silver grains have not been detected 
using probes for DIA, D-DIA, DIA-R or gp130 on morulae, although 
sections of morulae have been included in experiments when 
specific signals have been observed on older embryos. However, 
on all stages up to the morula a peculiar artifact has been 
observed. Accumulations of dark granules, which do not exactly 
resemble autoradiographic silver grains are often seen over the 
cytoplasm (fig. 3.6a). These were also detected in 1 and 2 cell 
embryos, even using the sense control probe for DIA. What these 
granules represent is not clear. They are unlikely to be melanin 
granules, since non-pigmented mice were used as donors for most 
of the specimens for in situ hybridisation. These accumulations 
made it difficult to detect any specific hybridisation, but authentic 
silver grains were rarely observed in areas not obliterated by the 
artifact at these early stages. In situ hybridisation has previously 
been performed on such early preimplantation stages to study the 
expression of the Oct-4 gene (Yeom et al., 1991). The very 
abundant transcripts for Oct-4 in these totipotent cells produce 
sufficient autoradiographic grains to obliterate completely any 
background artifact which would interfere with a less intense 
signal. The expression of mRNAs for FGF-4 and its receptor have 
been detected previously in the blastocyst (Niswander and Martin, 
1992; Rappolee et al., 1994) by in situ hybridisation. FGF-4 mRNA 
has also been seen in morulae, but at very low levels (Niswander 
Fig. 3.5 In situ hybridisation on sections of blastocysts at 4.5dpc 
immediately before implantation (x60 oil immersion). 
The probe for DIA hybridises to the trophectoderm, and also to 
a region over the 1CM adjacent to the blastocoel. 
Transcripts for mRNA for the diffusible form of DIA are located 
in the trophectoderm and in juxtacoelic regions of the 1CM. 
DIA-R mRNA is expressed mainly in the 1CM. 
The probe for gp130 hybridises predominantly to the 1CM, but 









L 	 4: 
-7' 
and Martin, 1992). 	The preimplantation artifact was apparently 
not a problem in that study. 
Uterine expression 
From 4.5dpc until 8.5dpc (all of the uterine stages studied), silver 
grains are seen in the endometrial glands using all 4 probes (fig. 
3.7). The levels differ slightly with stage and probe, but this may 
reflect the variability inherent in the procedure. The strongest 
endometrial gland signal is seen with the probe for gpl30 (fig. 
3.7d). The level of signal over the rest of the uterus tended to be 
higher generally for gpl30. Using the probe for DIA-R, a 
concentration of grains on the epithelium lining the uterine lumen 
was observed in addition to the distribution seen over the 
endometrial glands. This expression pattern seems to persist 
through all the stages studied, and is a phenomenon observed 
here only with the probe for DIA receptor (fig. 3.13). 
Postimplantation stages 
Specific transcripts could be detected in 5.5dpc postimplantation 
embryos using the full length DIA probe (fig. 3.6b). This signal 
was localised to the extraembryonic and ectoplacental cone region, 
consistent with the results on 6.5 and 7.5dpc embryos previously 
obtained using RNase protection (Rathjen et al., 1990b). In that 
Fig. 3.6 
In situ hybridisation on a section of a morula using a sense 
control probe for the DIA gene (x60 oil immersion). The black 
particles present in the cytoplasm do not represent 
autoradiographic grains. 
In situ hybridisation of a section through a 5.5dpc embryo (x20 
objective) using a probe for DIA. A few silver grains can be seen 
in the embryonic region (Emb) of the embryo, and a slightly 
higher concentration is present in the extra-embryonic (Ex emb) 
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report, mRNA for the D-form, and less for the M-form of DIA was 
seen in the extra-embryonic part of the egg cylinder with only a 
trace being detectable in the embryonic region. Appart from the 
expression always seen in the endometrial glands of the uterus, no 
clear signal for DIA mRNA could be detected in postimplantation 
embryos or their decidua. 
With the probe for DIA-R a significant concentration of 
grains could not be seen in any of the embryonic tissues at 5.5, 6.5 
and 7.5dpc, although there was a high level of expression in the 
decidual tissue surrounding the embryos (figs. 3.8a and c and 
3.9a), and a specific localisation of signal in the endometrial 
glands. The decidual expression was at its highest in proximal 
regions, and appeared to diminish with increasing age of the 
embryo. At 8.5dpc only a trace of the signal in the deciduum 
could be seen (fig.3.9c), but by this time other tissues such as the 
amnion, neural tube, somites and pre-somitic mesoderm were 
exhibiting significant deposits of silver grains (fig. 3.10). 
Gp130 was also expressed in the decidual tissue surrounding 
the embryo, but in contrast to the expression patterns seen with 
DIA-R, the level of gp130 increased with the age of the embryo 
(figs.3.8b and d and 3.9b and d). Gp130 expression was also 
apparent in most tissues at 8.5dpc, particularly the mesenchyme, 
amnion and visceral yolk sac (fig. 3.11). 
-.7,.- 
Fig. 3.7 In situ hybridisation on sections of uteri of 4.5 or 5.5dpc. 
In each case the autoradiographic grains localise to the 
endometrial glands (x20 objective). 
5.5dpc uterus using a probe for the whole of the coding region 
for DIA 
5.5dpc uterus using a probe specific for the diffusible form of 
DIA 
5.5dpc uterus using the DIA-R probe 
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Discussion 
The majority of previous reports of the expression of cytokines in 
the preimplantation mouse embryo have been based on the 
techniques of PCR and cDNA library screening (Rappolee et al., 
1988; 1992; Conquet and Brület, 1990; Lee et al.,1990; Rothstein 
et al., 1992). The inferences drawn from the PCR studies are that 
certain cytokines, such as epidermal, transforming, platelet-
derived and insulin-like growth factors (IGFs) are expressed in 
preimplantation embryos (Rappolee et al., 1988; 1992; Lee et al., 
1990). Expression of the mRNA for the receptors for IGF-I, IGF-II 
and insulin has also been reported from RT-PCR studies (Rappolee 
et al., 1992). Screening of the cDNA libraries revealed transcripts 
for IL-113, IL-6, and interferon-y at the blastocyst stage (Rothstein 
et al., 1992). IL-6 and DIA have been reported by PCR to be 
expressed in blastocysts (Murray et al., 1990; Conquet and Brület, 
1990). Inappropriate amplification of contaminating sequences is 
one of the hazards associated with the PCR technique, especially 
when the quantity of starting material is limited, as is the case 
with small numbers of preimplantation embryos (Conquet and 
Brület, 1990; Murray et al., 1990). Neither of the techniques used 
previously provides any information about the spatial distribution 
of the transcripts for the genes under investigation. Using in situ 
hybridisation the expression of a gene can be assigned 
unambiguously to specific tissues or cells. This technique has 
been used on preimplantation embryos in the study of FGF-4 
(Niswander and Martin, 1992). 
70 
Fig. 3.8 In situ hybridisation on sections of postimplantation 
embryos (x20 objective) using probes for the components of the 
DIA receptor 
5.5dpc using the DIA-R probe showing hybridisation to the 
decidual tissue surrounding the embryo 
5.5dpc using 	the probe for 	gpl30, which 	hybridises 	most 
strongly 	to the decidual tissue around the embryo 
6.5dpc showing transcripts for DIA-R mRNA in the decidual 
tissue around the embryo 
EPC=ectoplacental cone 
Ex Emb=extra-embryonic region of conceptus 
Emb=embryonic region 
6.5dpc using the gpl30 probe showing expression particularly 





















- 	 .. 
• 	 Embryonic 






. 	 •-••-- '..• 
•: 
r 	 • 
.4 
- 	-. 	•.••• 	 • 
4 	,•••' 	 4• ( 	 •• 	 A 
••-'•- 
	
4•. -• 	-S 	
4 	 - 	 ; 	 -•-- 
- 	- 	:*. 	tdL, • 
/••s 	 ' 	 •( 	
r 
p. 
d -., • 	,•-• - 
is 
' 	-4 
- - 	 • 
t•k 
•'.,- 





•, 	• -..f 	_•4 
4r 
A 
j • • 
4p 







Clear and specific localisation of the grains is evident in the 
blastocysts investigated here using probes for DIA and the 
components of its receptor. DIA mRNA transcripts can be 
detected in the trophectoderm, but not significantly in the 1CM 
(figs. 3.3a, 3.4a and b, 3.5a and b). In contrast, mRNAs for the DIA 
receptor components predominate in the 1CM, with little 
expression of DIA-R in the trophectoderm (figs. 3.3b and c, 3.4c 
and d, 3.5c and d). For gpl30, in addition to the significant 
expression seen in the 1CM, there are more grains in the 
trophectoderm than encountered with DIA-R. This may reflect 
the more ubiquitous role of gpl30 owing to its involvement in the 
receptor complexes of other cytokines such as interleukin-6 (IL-
6), ciliary neurotrophic factor (CNTF) and oncostatin M (OSM; Hibi 
et al., 1990; Gearing et al., 1992; Ip et al., 1992b). 
The expression patterns for DIA and the components of its 
receptor are suggestive of a paracrine interaction between the 
first tissue to differentiate, the trophectoderm, and the 
pluripotential 1CM. The implication is that the cells of the 
trophectoderm produce DIA, which binds to the receptors on the 
1CM cells, enabling them to remain in an undifferentiated state. 
The trophectoderm cells in the region between the 1CM and 
the blastocoel produce processes that extend over the 1CM cells, 
covering about 80% of their surface (Fleming et al., 1984). These 
trophectodermal processes are present from the onset of 
cavitation. Grains in blastocysts which were hybridised with a 
probe for DIA can occasionally be seen in regions which may 
represent these trophectoderm processes (fig. 3.12). As 
R. 
Fig. 3.9 In situ hybridisation 	on section of postimplantation 
embryos using probes for the componenets of the DIA receptor 
7.5dpc (xlO objective) using the DIA-R probe, which hybridises 
to the deciduum close to the embryo 
Emb=embryonic region 
Ex Emb=extra-embryonic region 
EPC=ectoplacental cone 
7.5dpc (xlO objective) showing transcripts for gpl30 in the 
decidual tissue around the embryo 
8.5dpc (x4 objective) showing transcripts for DIA-R mRNA in a 
small area of the deciduum near the placenta 
P=placenta 
A=amnion 
H = head fold 
VYS=visceral yolk sac 
8.5dpc (x4 objective) showing transcripts for gpl30 over most 
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development proceeds, these processes are gradually withdrawn, 
but traces persist even when the blastocyst is fully expanded. 
Blastocysts of 4.5dpc and in implantation delay may also possess 
the remains of such processes, so any grains detected in the 
juxtacoelic region of the 1CM may represent signal from either the 
presumptive primitive endoderm or from the trophectoderm 
processes. 
In the 	results 	presented here, the 	absence of 	significant 
numbers of 	detectable 	silver 	grains on morulae suggests 	either 
that 	DIA and 	the 	components of its 	receptor are 	not 	being 
expressed at 	this 	stage, 	or 	that they are 	being 	transcribed 	at 	a 
level 	beneath 	the 	sensitivity of detection 	by the 	in 	situ 
hybridisation technique. The small number of cells present at this 
stage (8-16), and the low nuclear to cytoplasmic ratio encountered 
during cleavage means that the amount of mRNA per embryo at 
these stages is likely to be very low. The apparent artifact of 
granular material in the blastomeres (fig. 3.6a), which seems to be 
restricted to early preimplantation embryos, also makes detection 
of autoradiographic grains very difficult. It has not, therefore, 
been possible to detect any signal in such early embryos in this 
study. 
Since the onset of this work mice lacking functional DIA 
have been generated (Stewart et al., 1992; Escary et al., 1993; 
Smith et al., unpublished). Surprisingly, the embryos are viable 
up to the blastocyst stage, and can develop to adulthood, 
providing the host uterus is wild type or heterozygous. DIA is not, 
therefore, indispensible for development of the preimplantation 
Fig. 3.10 In situ hybridisation on sections of 8.5dpc embryos (x20 
objective) using a probe for DIA-R 
Section through the trunk region showing expression of DIA-R 
over most tissues, especially the neural tube, somites and 
me sen c h ym e 
NT=neural tube 
S=somite 
Section through the anterior region showing transcripts for 
DIA-R in the visceral yolk sac (VYS), amnion (A), neural tissue and 
me sen c h y me 
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embryo. It is possible that DIA has no role in early development, 
but the specific expression patterns of the mRNAs for DIA and its 
receptor seen in blastocysts by in situ hybridisation suggest some 
function. The most likely role for DIA in this context, considering 
its ability to inhibit the differentiation of ES cells in culture, is in 
the maintenance of the stem cells in the 1CM. 	An alternative 
means for achieving this may be available. 	However, the 
possiblity that DIA has no purpose in the early embryo, or that it 
is involved in some other function cannot be ruled out. 
By the time the blastocyst is ready to implant at 4.5dpc, the 
mural trophectoderm cells have undergone giant cell 
transformation and the primitive endoderm has begun to 
differentiate on the blastocoelic surface of the 1CM. The 
expression patterns of DIA and its receptor complex observed in 
the 3.5dpc blastocyst are maintained. The layer of cells on the 
blastocoelic surface of the 1CM is able to overcome the inhibition 
of differentiation and become the primitve endoderm (see chapter 
1, fig 1.1a). How this is achieved is not known, but it probably 
involves the action of additional differentiation factors. The 
remaining undifferentiated 1CM tissue is now known as the 
primitive ectoderm or epiblast. The pluripotential state of this is 
maintained for several more days. 
Transcripts for DIA have been detected in postimplantation 
embryos by RNase protection studies (Rathjen et. al., 1990b). By 
crude dissection of the egg cylinders into embryonic and extra-
embryonic regions, expression has been localised to the extra-
embryonic portion (Rathjen et. al. 1990b). This conforms with the 
Fig. 	3.11 In 	situ 	hybridisation 	on a 	section through 	the 	anterior 
region of an 8.5dpc embryo using a probe for gp130 
a. 	Transcripts 	for gpl30 	are 	present on all tissues 	seen 	in 	this 
section, 	but 	are more 	apparent 	over the deciduum, 	amnion, 
visceral yolk sac (VYS) and mesenchyme (xlO objective) 






















clearly understood, but they may play a role in implantation. The 
finding that mutant female mice which do not produce active DIA 
are unable to support implantation lends weight to this idea 
(Stewart et al., 1992). However, endometrial glands are present in 
the uterus of homozygous DIA negative female mice several days 
after fertilisation (fig. 7.2). The observation that both DIA-R and 
gpl30 mRNAs are also concentrated in the uterine endometrial 
glands suggests an autocrine activity for DIA in this tissue. In 
addition to its expression in the endometrial glands, DIA-R mRNA 
is found in the epithelium lining the uterine lumen (fig. 3.13), 
which may also be somehow involved in implantation. Such an 
elevation of signal is not seen with gpl30. The reason for this is 
not known, but it serves to demonstrate that the expression of 
DIA-R and gp130 are not always under the same regulatory 
control. It has not been possible to obtain a probe specific for the 
putative soluble form of DIA-R, but it seem likely that the 
expression of DIA-R seen in the epithelium lining the uterine 
lumen may represent the soluble form. The expression of this 
form is more likely to serve some function in the absence of 
coordinate expression of gpl30. 
DIA-R and gpl30 mRNAs are seen in the decidual tissue 
surrounding the embryo in all of the postimplantation stages 
studied (figs. 3.8 and 3.9). The level of DIA-R mRNA in the 
deciduum appears to decrease at 8.5dpc (fig. 3.9c), whereas that 
of gpl30 increases (fig. 3.9d). This provides another example of 
the independent regulation of expression for DIA-R and gpl30. 
At the egg cylinder stage the levels of transcripts for DIA-R mRNA 
Fig. 3.12 In situ hybridisation on sections of blastocysts (x60 oil 
immersion objective) using a probe for DIA. Transcripts are 
apparent in the trophectoderm, but also in the regions of the inner 
cell mass (1CM) adjacent to the blastoceol, which may represent 
either presumptive primitive endoderm or trophectoderm 














are not significantly above background in the embryo (fig. 3.8a 
and c, fig. 3.9a). This indicates a down-regulation in the 
production of DIA-R around the time of implantation. This is 
consistent with the gradual restriction in pluripotency that occurs 
during gastrulation, and suggests an alteration in cytokine 
dependence. Low level expression of gp130 is seen over most of 
the tissues at this stage (figs. 3.8b and d, fig. 3.9b). At 8.5dpc 
there is an obvious increase in expression of DIA-R in most 
tissues, including the neural tube, amnion, visceral yolk sac and 
pre-somitic mesoderm (fig. 3.10). Similar, but higher 
concentrations of grains are seen using the probe for gp130 (fig. 
3.11). DIA-R and gp130 are components of the receptors for CNTF 
and OSM; the expression of these subunits may, therefore, reflect 
some function of either of these cytokines. Transcripts for DIA-R 
are evident in the neural plate/neural tube region of 8.5dpc 
embryos (fig. 3.10). As will be seen in chapter 4, this correlates 
with the detected expression of the CNTF-specific receptor 
component at the same stage. 
There are several possible explanations for the abundance of 
transcripts for DIA-R and gp130 in decidua, some of which may 
be clarified by the availability of probes for the soluble form of 
DIA-R. The production of DIA by the endometrial glands may be 
detrimental to the embryo following implantation. Exposure of 
the developing embryo to elevated levels of DIA can cause 
abnormalities (Conquet et al., 1992; see chapter 6). Receptors on 
the decidual cells 	surrounding the embryo may serve 	to capture 
the DIA and prevent it from reaching the embryo. 	Alternatively, 
Fig. 3.13 In situ hybridisation on sections through a uterus at 
4.5dpc (x60 oil immersion objective) using a probe for DIA-R. 
Transcripts localise to the epithelium lining the uterine lumen 






























the embryo may benefit from the DIA produced by the uterus, 
and the receptors in the deciduum are involved in delivery of DIA 
to the embryo. In this case, a soluble form of the receptor would 
be required. The presence of mRNA for the DIA receptor may, 
alternatively, suggest a role for DIA in decidual function. The 
deciduum is thought to be involved in nutrition of the embryo 
(Finn, 1969). The cells closest to the embryo possess large 
numbers of ribosomes and intracellular fibrils and an extensive 
endoplasmic reticulum. The localisation of mRNAs for the 
components of the DIA receptor to this region implies that these 
cells are targets for DIA. The inability of female mice lacking DIA 
to support implantation (Stewart et al., 1992; Escary et al., 1993; 
Smith et al., unpublished) may be related to the involvement of 
DIA in the action of the deciduum, particularly in the process of 
its initiation. 
The differential expression patterns of both DIA and its 
receptor in the mouse blastocyst documented here provide strong 
evidence for the involvement of DIA in development of the early 
mouse embryo. The finding since the onset of this work, that 
embryos can develop until implantation in the absence of DIA 
(Stewart et al., 1992; Escary et al., 1993; Smith et al., 
unpublished), suggests that either DIA is not required for early 
development, or that some other molecule is able to fulfil the 
same role. In the following chapter, the expression patterns of 
other cytokines which operate via the same signal transduction 
pathway as DIA will be considered. 
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CHAPTER 4 
CLONING AND EARLY EMBRYONIC EXPRESSION OF THE MURINE CNTFR GENE 
Introduction 
The finding that mutant embryos lacking DIA are able to survive 
up to the blastocyst stage without any additional administration of 
DIA, and can reach adulthood in non-mutant or heterozygous foster 
mothers implies that there is not an absolute requirement for DIA 
in early mouse development (Stewart et al., 1991). It is possible 
that the role of stem cell maintenance in the embryo can be 
achieved by DIA in the normal situation, but another means must 
exist. The receptor for DIA contains a signal transduction subunit, 
gpl30, which is also involved in the receptor complexes of a 
number of other cytokines, including interleukin-6 (IL-6), ciliary 
neurotrophic factor (CNTF) and oncostatin M (OSM). Providing that 
the other components of the receptor complex are available, each of 
these cytokines is able to inhibit the differentiation of ES cells when 
added to the culture medium (Yoshida et al., 1994; Conover et al., 
1993; Wolf et al., 1994; Rose et al., 1994). These cytokines may, 
therefore, be considered as possible candidates for maintaining the 
stem cells in the early embryo. A necessary criterion for the 
involvement of any of these cytokines in early development is their 
availability to the embryo in utero. 
Maintenance of ES cells by IL-6 in culture requires the 
provision of the soluble IL-6-specific receptor component (sIL-6R; 
Yoshida et al., 1994). Since the sIL-6R component is absent from ES 
cells (Saito et at, 1992), it is unlikely to be produced by the cells of 
the 1CM. Possibly, it may be produced and secreted by the cells of 
the trophectoderm. Blastocysts have been shown previously to 
express IL-6 mRNA, and to secrete IL-6 protein into the medium 
during culture (Murray et al., 1990). What function the IL-6 serves 
at this stage is unknown. So far, there is no evidence that IL-6 can 
operate via an alternative signal transduction pathway to that 
initiated by gpl30. In the ES cell system the maintenance of the 
undifferentiated state in culture is dependent upon the provision of 
the soluble receptor in addition to the ligand (Yoshida et al., 1994). 
Although murine ES cells can be maintained in an 
undifferentiated state by the supplementation of the medium with 
human OSM, to date, attempts to clone the murine form of OSM 
have proved difficult. This is likely to reflect a dissimilarity in the 
genes for the two species. A human probe is, therefore, unlikely to 
bind very specifically to murine tissues during in situ hybridisation. 
No signal has been detected by Northern or Southern hybridisation 
on murine RNA or DNA using the probe for human OSM (C. Dani, 
unpublished). A study of the expression patterns of this cytokine 
in the developing mouse embryo has not yet been attempted. 
The amino acid sequences for the CNTF-specific receptor 
component (CNTFR) of the rat, rabbit and human are extremely well 
conserved, having a homology of 94% (Ip et al., 1993). It seems 
likely that the mouse form will also be very similar. The procedure 
selected for cloning the murine CNTFR, therefore, was reverse 
transcription polymerase chain reaction (RT-PCR). This approach 
was also adopted for the CNTF ligand, although the amino acid 
sequence of this molecule is a little less well conserved between the 
species studied (Ip et al., 1993). The murine form of CNTFR was 
successfully cloned, from mouse cDNA, as verified by sequencing 
(figs. 4.1-4.3), but the mouse form of CNTF could not be easily 
isolated using this method. In situ hybridisation was, therefore, 
W. 
carried out on sections of embryos using probes generated from the 
mouse form of CNTFR and the rat form of CNTF. 	Previous Northern 
hybridisation analysis 	on 	adult 	rat 	tissues 	has 	revealed 	that 
transcripts for CNTFR are mainly restricted to the nervous system, 
in 	particular the 	olfactory 	bulb, 	thalamus, 	midbrain, 	hindbrain, 
spinal 	cord 	and 	peripheral 	nerves 	(Ip 	et 	al., 	1993), 	and 	also 	to 
skeletal muscle (Davis et al., 1991). 	In the embryo CNTFR mRNA 
has been found by Northern analysis and in situ 	hybridisation 	to 
predominate in neural tissue and derivatives of the neural crest (Ip 
et 	al., 	1993). Although the levels are significantly lower, CNTF 
mRNA has been shown by Northern blotting to have a similar 
distribution 	in both 	adult 	and 	embryonic 	rats 	(Ip 	et 	al., 	1993). 
However, another study has failed to detect any CNTF protein in 
embryonic rats (M. 	Sendtner, unpublished). 
Here, in situ hybridisation has been carried out on sections 
of blastocysts and 8.5dpc embryos using probes for mouse IL-6, rat 
CNTF and mouse CNTFR to investigate the potential involvement of 
any of these cytokine systems in development of the early mouse 
embryo. 
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Materials and Methods 
The mouse CNTFR gene was cloned using RT-PCR, as described in 
chapter 2. The oligonucleotide primers used for cloning the mouse 
CNTFR were predicted from the published rat and human CNTFR 
protein sequence (Ip et al., 1993). The first were from amino acids 
121 to 126 (oligo A) and 282 to 287 (oligo B). These were selected 
because they are identical in the rat and human and have the same 
predicted melting temperatures (49°C). They flank a sequence of 
498 base pairs (bp). A successful series of PCR amplification 
should, therefore, generate a fragment of about 498bp To increase 
the probability of amplifying the desired sequence from cDNA, 
another primer in the 5' region was selected to generate a shorter 
fragment of 41 lbp. This oligonucleotide (oligo C) had a predicted 
melting temperature of 49°C. A second round of PCR was 
performed upon the product generated by the reaction using the 
original primers, to obtain a new product of the appropriate size 
(41lbp). This fragment was amplified and subcloned into 
pBluescript II KS (fig) and its authenticity verified by sequencing, 
as described in chapter 2. The template was linearised using Sail, 
and a radioactively labelled probe synthesised from the T7 
promoter using either 35 S-labelled CTP or 33 P-labelled UTP (see 
chapter 2). In situ hybridisation was performed using the CNTFR 
probe on sections of mouse blastocysts (3.5dpc) and 8.5dpc 
embryos. 
Fig. 4.1 DNA sequence as read from the sequencing gel for part of 
the murine form of the ciliary neurotrophic factor-specific 
receptor subunit (mCNTFR) 
IpI 
Fig. 4.1 
10 	20 	30 	40 	50 
ihhiluil 	hlilhhlhi 	 • 	illihilhl 	lilt. 	.1111.1111 	• 	11.11.1 
ncN'rFR/A T3 13 / 8/93 (1>256)-> CCAGCCCTCAAGAACCGCTGCCACAT 
AAGATGATGGTATGTGAGAAGGACCCAGCCCTCAGCCGcTGCCACAT 
60 	70 	80 	90 	100 
iIilIlihhuhhiilhhhl,li 	.•lh.ihhiihhlhl.hlh.i 	11111.1 
rrQTFR/A T3 13 / 8 / 93(1>256)-> 
TCGGTACATGCACCTGrCTCAACCATCAAGTACAAGGTCTCCATA1.GTG 
110 	120 	130 	140 	150 
hhhIlhhhhlihihlhh. 	hll.hilihhhlihi 	ll,hihlhhi 	11111.1 
ncNTFR/A T3 13 / 8 / 93(1>256)-> 
TCAGCAACGCCTTGGGTCACAACACTACGGCCATCACCTTTGACGAATTC 
160 	170 	180 	190 	200 
•ii.i.ii 	I 	11111111 	till 	1111111. 	lii.iliiitl 	p... 	liii 	ii 
rrcNTFR/A T3 13 / 8/93 (1>256)-> ACcArrGTGAAGCCTGATCcrCcAGCGTGGTcCCGGccAGTGcc 
ACCATGTGAAGCCTGATCCTCCAGkCGTGGTGGCCCGGCCAGTGCC 
210 	220 	230 	240 	250 
•i.l..i.l....l... 	.l.•,,l..•,l 
xrcNrFR/A T3 13 / 8/93 (1>256)-> CAGCAACCCCCGTCGGCTGGPGGTGACATGGCAGCACCCTCAAC7rGGC 
rrcNTFR/A T7 13/8/93 (1>191)< GCCAGACACcCTCAAC1rGGc 
CAGCAACCCCCGTCGGCTGGAGGTGACATGGCAGACACCCTCAACTTGGC 
260 	270 	280 	290 	300 
1.11111 	liii 	jul. 	111111111.1 	liii.. 	liii, 	iii 	.11111111 
rrcNTFR/A T3 13/8/93(1>256)> cccc-Ac-rrrc 
rrQTFR/A T7 13 / 8/93 (1>191 )<- CCGCCCTGAATCCTFCCTCAAGrrCCCTCCGCTACCGGCCTC 
CCG.CCCTGATCCTrrCcTCTCAAGrrCTrCCTGCGcTACCGGCCTCTC 
- 310 	320 	330 	340 	350 
h.lulhhhhlh,h,l,i 	III. 	huhlh,uihiihhlhh. 	.11.1.11 	hIll 
ncNTFR/A T7 13 / 8/93 (1>191)<- ATCCTGGACCAATGGCAGCATGTGGAGCTCTCGGATGGCACAGCACACAC 
ATCcTGGACCAATGGCAGCATGTGGAGCTCTCGTGGCACAGCACACAC 
360 	370 	380 	390 	.400 
hut.. 	11111111111.1.1111.11111.111.1111.111111 	III 
ircNTFR/A T7 13 / 8 / 93(1>191 )<- CATCACAGATGCCTACGCAGGGAAGGAATACATCATCCAGGTGGCAGCrA  
CATCACAGATGCCTACGCAGGGAAGGAATACATCATCCAGGTGGCAGCCA 
410 
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The published amino acid sequences for CNTF of the rat, human and 
rabbit show a reduced similarity compared with those of CNTFR 
(Stöckli et al., 1989; Ip et al., 1993). However, attempts were made 
to clone the mouse form of CNTF by the method described above for 
CNTFR, but as the desired band was not apparent on the gel 
following PCR, even using the nested primer technique, sub-cloning 
and probe synthesis was carried out using the rat form of cDNA. As 
the procedure adopted for this was very similar, and run in parallel 
with the preparation of the mouse CNTFR probe, it is not described 
separately in detail here. Oligonucleotide primers were predicted 
from the published protein sequences for rat and human CNTF to lie 
in regions of complete identity between the two species (Stöckli et 
al., 1989). For the first round of PCR the oligos used were from 
amino acid 38 to 43 and 137 to 142. From these, a fragment of 
312bp should be amplified. Primer nesting was performed by 
replacing the latter oligo with one from amino acids 102 to 107 to 
generate a fragment of 207bp when PCR was performed on the 
product of the previous reaction. This fragment was gel purified 
and subcloned into pBluescript II KS (fig) using Sall and BamHl 
restriction sites which had been included in the oligo pairs. 
Authenticity of the product as rat CNTF cDNA was established by 
sequencing. The plasmid was linearised with Sail and 
radioactively-labelled probe synthesised by transcription from the 
T7 promoter. In situ hybridisation was performed as described on 
sections of 3.5 and 8.5dpc embryos (see fig). 
Itrz 
Fig. 4.2 Comparison of the DNA sequence of the murine form of 




Seql(1>-414) 	Seq2(1>1194) 	Similarity 	Gap 	Gap Consensus 
mCNTFR con RAT CNTFR DNA SEQ Index Number Length 	Length 
(4>162) 	 (531>689) 	 96.9 	0 	0 159 
,,1O 	r20 c30 '.40 	,50 	,r60 	,.r70 	.80 
mCNTFR con 	AAGATGATGGTATGTGAGAAGGACCCAGCCCTCAAGAACCGCTGCCACATTCGGTACATGCACCTGTTCTCAACCATCAA 
AA ATGATGGT TGTGAGAAGGACCCAGCCCTCAAGAACCGCTG CACATTCGGTACATGCACCTGTTCTCAACCATCAA 
RAT CNTFR DNA SEQ AAAATGATGGTCTGTGAGAAGGACCCAGCCCTCAAGAACCGCTGTCACATTCGGTACATGCACCTGTTCTCAACCATCAA 
530 	540 	4 550 	560 	570 	580 	-590 	600 
,,9O 	floo 	,.rllO 	f120 	c130 	'.140 	.150 	'.160 
mCNTFR con 	GTACAAGGTCTCCATAAGTGTCAGCAACGCCTTGGGTCACAACACTACGGCCATCACCTTTGACGAATTCACCATTGTCA 
GTACAAGGTCTCCATAAGTGTCAGCAACGCCTTGGGTCACAACAC ACGGC ATCACCTT GACGAATTCACCATTGTGA 
RAT CNTFR DNA SEQ GTACAAGGTCTCCATAAGTGTCAGCAACGCCTTGGGTCACAACACCACGGCTATCACCTTCGACGAATTCACCATTGTGA 
610 	4 620 	4-630 	4 640 	4 650 	660 	670 	680 
mCNTFR con 	AG 
AG 
RAT CNTFR DNA SEQ AG 
Mouse IL-6 
The full length murine IL-6 fragment of 650bp subcloned into pUC 
was supplied by T. Taga. For probe synthesis, this fragment was 
released by digestion with Xbal and BamHl and subcloned into 
pBluescript II KS (fig). Linearisation was performed using EcoRl, 
and transcription to generate a radioactively-labelled probe 
initiated by means of the T7 promoter. 
TOP 
Fig. 4.3 Comparison of the protein sequence for mouse CNTFR 
with that of the rat. There is one amino acid at position 112 
which is different between the two species. 
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Fig. 4.3 
Seql(1>138) 	Seq2(1>372) 	Similarity 	Gap 	Gap Consensus 
M CNTFR PROTEIN RAT CNTFR PROTEIN Index Number Length 	Length 
(1>138) 	 (150>287) 	 99.3 	0 	0 138 
riO 	f20 f30 f40 	q50 	,60 	c70 	c80 
M CNTFR PROTEIN 	KMMVCEKDPALKNRCHIRYMHLFSTIKYKVSISVSNALGHNTTAITFDEFTIVKPDPPENVVARPVPSNPRRLEVTWOTP 
KMMVCEKDPALKNRCH I RYMHLFST I KYK VS I SVSNALGHNTTAI TFDEFT I VKPDPPENVVARPVPSNPRRLEVTWOTP 
RAT CNTFR PROTEIN KMMVCEKDPALKNRCHIRYMHLFSTIKYKVSISVSNALGHNTTAITFOEFTIVKPDPPENVVARPVPSNPRRLEVTWOTP 
-150 	4 160 	4 170 	4-180 	1190 	4-200 	4210 	220 
	
dO0 rhO r120 c130 
M CNTFR PROTEIN 	STWPDPESFPLKFFLRYRPLILDOWQHVELSDGTAHTITDAYACKEYI IOVAAKONEI 
STWPOPESFPLKFFLRYRPL I LDOWQHVELS: CTAHT I TDAYAGKEY II OVAAKDNE I 
RAT CNTFR PROTEIN STWPDPESFPLKFFLRYRPLILDQWOHVELSNGTAHTITDAYAGKEYI IQVAAKDNEI 
4230 	4240 	4-250 	260 	-270 	4280 
Results 
The resultant amplified portions of mouse CNTFR and rat CNTF 
cDNAs were successfully cloned into pBluescript KS II. The identity 
of the clones was established by sequencing (Fig) and Southern 
hybridisation to rat cDNA from the PCR reaction. Although several 
bands were present on the agarose gel in addition to the one of the 
expected size, only one band was obtained following Southern 
blotting. The single band obtained indicated that neither probe 
cross-reacted with any other gene, and that there were no 
alternative transcripts for CNTF or CNTFR (data not shown). 
Radioactively-labelled probes were synthesised for in situ 
hybridisation (chapter 2). 
Using the mouse CNTFR probe, grains localised to the 
neural plate/neural tube region and also to the neural crest on 
sections of 8.5dpc embryos (figs). A few grains could be 
distinguished in the 1CM region of 3.5dpc blastocysts (figs), but the 
intensity of the signal was significantly lower than that observed in 
the neural regions of the 8.5dpc embryos. A higher signal was seen 
using a probe for the DIA receptor on sections of blastocysts 
(chapter 3, fig), although this experiment was performed on a 
separate occasion, and variability between runs can be a problem 
with in situ hybridisation. However, both probes have been used in 
several experiments, and the characteristic intensity of expression 
was maintained. The DIA-R probe (980bp; see chapter 3) is more 
than twice the length of the CNTFR probe (41 lbp). Previous studies 
have indicated that longer probes yield weaker signals; the 
suggested explanation for this is that the longer probe is less well 
Fig. 	4.4 Diagrammatic representation 	of the plasmids 	used 	to 
generate the probes for in situ hybridisation to 	investigate 	the 
expression of some of the components of cytokine systems which 
utilise gp130 as part of the receptor 
A probe for murine ciliary neurotrophic factor receptor 
(mCNTFR, 414bp) is synthesised by linearisation of the plasmid 
using Sail and transcription from the 17 promoter 
A probe for the rat form of CNTF (rCNTF, 220bp) can be made 
by linearisation of the piasmid using Sail and transcribing from 
the T7 promoter 
C. 	An interieukin-6 (IL-6, 600bp) probe is created by 
linearisation of the plasmid with EcoRl and transcription from the 
T7 promoter 
II1) 
Fig. 4.4 	 Pall 
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a 	 mCNTFR (414bp 
pmCNTFR (in PBS) 
3.40 Kb 










able to penetrate into the cross-linked tissue (Wilkinson and Green, 
1990). Therefore, in the light of the significant signal observed on 
sections of 8.5dpc embryos probed for CNTFR, the few grains seen 
on the ICMs of the blastocysts using the same probe probably 
represent either background or lower expression levels of the CNTF 
receptor gene compared to that of the DIA receptor. 
No specific signal could be seen on sections of either 3.5 or 
8.5dpc mouse embryos using the probe for rat CNTF. Previous 
studies have failed to detect CNTF mRNA in rat embryos by in situ 
hybridisation (Stöckli et al., 1989; 1991), and transcripts are barely 
detectable by Northern blotting in the 14dpc rat embryo (Ip et al., 
1993). 
There was no obvious hybridisation on sections using the 
probe for IL-6, 	either 	in blastocysts or in 	8.5dpc embryos. 	The 
expression patterns of IL-6 mRNA in embryos prior to the onset of 
haematopoiesis has not been documented, although the presence of 
IL-6 mRNA in blastocysts and secretion of the protein from these 
has been reported (Murray et al., 1990). A positive control for the 
probe in this series of in situs was not available, and for this reason, 
it is difficult to draw conclusions from this data about the 
expression patterns of IL-6 in the early embryo. 
Ill 
Fig. 4.5 In situ hybridisation on a section through an 8.5dpc 
embryo using a probe for mCNTFR (x4 objective). No grains are 
visible at this magnification; the figure was included for the 
purpose of orientation for subsequent figures 
Al=allantois 
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Discussion 
Transcripts for CNTFR mRNA are clearly detectable by in situ 
hybridisation in the 8.5dpc embryo and are localised to the neural 
plate/neural tube and neural crest (figs. 4.5-4.7). These are 
expected targets for a cytokine playing a role in neural 
development (Adler et al., 1979; Lin et al., 1989; Stöckli et al., 
1989), and are consistent with the expression patterns previously 
observed in later rat embryos (Ip et al., 1993). A few 
autoradiographic grains can be seen in the ICMs of 3.5dpc 
blastocysts, but these are at rather equivocal levels (fig. 4.8). 
However, this is the region in which expression of CNTFR would be 
anticipated if CNTF is able to act on the 1CM to maintain the cells in 
their undifferentiated state. 
The absense of detectable CNTF mRNA in these embryonic 
stages suggests that CNTF is unlikely to be involved in early 
development, although the possibility that the protein is provided 
by the mother cannot be ruled out. There was no significant 
concentration of silver grains on any of the sections probed here 
with CNTF. This is probably because CNTF mRNA is not produced 
during any of the embryonic stages used in this study. Although 
CNTF is abundantly expressed in peripheral nerves, myelinating 
Schwann cells and reactivating astrocytes (Williams et al., 1984; 
Manthorpe et al., 1986; Rende et al., 1992; Sendtner et al., 1992; 
Friedman et al., 1992; Ip et al., 1992), cytokines are generally 
active at low concentrations. It is possible that CNTF is actually 
transcribed at the embryonic stages studied, but at a level that is 
undetectable by in situ hybridisation. However, a feature of CNTF 
i,cz• 
Fig. 4.6 In situ hybridisation on a section through an 8.5bn 
embryo in a region similar to that of fig. 4.5 using a probe for 
mCNTFR 
Transcripts for mCNTFR mRNA can be seen in the neural tissue 
and neural crest of the headfold (x20 objective) 
A higher magnification of fig. 4.6a (x60 oil immersion 
objective) 
Fig. 4.6 
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which may reduce its potential efficiency as a signalling molecule in 
the early embryo is the absence of any hypertrophic leader 
sequence, causing it to be retained in the cytoplasm (Dittrich et al., 
1994). Restricion of the cytokine to the cytoplasm of the cell by 
which the molecule is synthesised may render CNTF an unlikely 
candidate for paracrine interactions. 
In the case of DIA, transcripts are known to be present in 
the extra-embryonic region of the 6.5dpc embryo from RNase 
protection analysis (Rathjen et al., 1990b), but are not obvious by in 
situ hybridisation. The CNTF probe administered to the sections 
was made using the rat form, which may be less sensitive when 
applied to a heterologous species such as the mouse. Previous 
reports of in situ hybridisation using a rat CNTF probe on rat 
embryonic tissues at 15dpc have failed to detect any transcripts 
(Ip et aL, 1993; Stockli et al., 1989, 1991), although CNTF mRNA has 
been observed in this embryonic stage by Northern blotting (Ip et 
al., 1993). It is possible that CNTF is present in the blastocyst at 
levels undetectable by in situ hybridisation. 
One of the properties of DIA which led to the suggestion 
that it may be involved in stem cell proliferation in the early 
embryo is its ability to support ES cells and to enable their 
derivation de novo from blastocysts in culture. The addition of 
CNTF to culture medium has been shown to inhibit the 
differentiation of established ES cells (Conover et al., 1993; Wolf et 
al., 1994), indicating that ES cells probably possess the relevant 
receptors for the action of CNTF. However, experiments in which 
BAF-1303 cells (which express neither gp130, nor the specific 
receptor components for DIA and CNTF) were transfected with the 
DIA-specific receptor component and gp130 resulted in 
TI 
Fig. 4.7 in situ hybridisation on a section through a more 
posterior region of an 8.5dpc embryo than that of fig. 4.6 using 
the mCNTFR probe 
A low magnification section for orientation purposes (x4 
objective) 
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proliferation of the cells upon exposure to CNTF (Gearing et al., 
1994). This occured even in the absence of the CNTF-specific 
receptor component, although addition of this subunit did enhance 
the activity. This suggests that, contrary to previous understanding 
(Ip et al., 1993), CNTF may be able to elicit a response in the 
absence of its specific receptor subunit. 
Attempts to isolate ES cells from blastocysts in medium 
supplemented with CNTF have yielded a significantly lower 
proportion of lines compared with the relatively high number 
obtained with DIA, OSM or IL-6 +sIL-6R (see chapter 5). One 
possible interpretation of this phenomen is that the receptor for 
CNTF is not expressed in the blastocyst at sufficient levels to 
facilitate adequate binding of CNTF for the effective initiation of the 
signal transduction pathway in this system. During the expansion 
of ES cell lines, the expression of the CNTF receptor may be up-
regulated, enabling the preservation of established ES cells by the 
supplementation of the medium with CNTF (Conover et al., 1993). 
Preliminary analysis by RNase protection indicates that mRNA 
transcripts for the CNTF-specific receptor subunit are present on ES 
cells; the expression levels increase as the ES cells differentiate (M. 
Robertson, unpublished). 
Reports have recently emerged in which mice lacking IL-6 
(Poli et al., 1994; Kopf et al., 1994) and CNTF (Masu et al., 1993) 
have been generated. For neither cytokine was the phenotype 
lethal during embryonic stages, although adult animals were 
affected in certain tissues. The conclusion from these results is that 
neither IL-6 nor CNTF is essential during development. 
Since OSM can act on target cells via the DIA receptor 
complex (Gearing et al., 1992; 1994), this may be considered as a 
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Fig. 4.8 In situ hybridisation on a section through a 3.5dpc 
blastocyst (x60 oil immersion objective) using the probe for 
mCNTFR. Very few grains can be seen over the inner cell mass 
(1CM) region 
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more likely alternative candidate for embryonic stem cell 
maintenance. This question will remain unanswered until the 
murine form of OSM has been cloned and suitable probes for in situ 
hybridisation to sections of mouse embryos can be generated. 
1 -) Li. 
CHAPTER 5 
ESTABLISHMENT OF PLURIPOTENTIAL ES CELL LINES FROM 
BLASTOCYSTS IN CULTURE USING MEDIUM SUPPLEMENTED WITH 
ALTERNATWE CYTOKINES 
Introduction 
One of the features of DIA supporting the suggestion that it may be 
involved in the maintenance of the stem cells in the developing embryo 
is its ability to act directly on mouse blastocysts in culture, resulting in 
the generationde novo of pluripotential ES cell lines (Nichols et aL, 1990; 
Pease et al., 1990). Any other molecule considered as a candidate for 
the inhibition of differentiation in the early embryo would also be 
expected to fulfil such a role on blastocysts in culture, thus illustrating 
that the pluripotential cells in the early embryo are able to respond to 
such a factor. The cytokines which, in common with DIA, have recently 
been found to operate via receptors which utilise the signal transducing 
subunit gpl30, (Gearing et al., 1992; Murakami et al., 1992; Ip et al., 
1992), have been considered as likely alternatives to DIA in this 
context. Oncostatin M (OSM), ciliary neurotrophic factor (CNTF) and 
interleukin-6 (IL-6), supplemented with the soluble form of its specific 
receptor component (sIL-6R) have been shown to inhibit the 
differentiation of pre-existing ES cells when added to the culture 
medium in very low concentrations (Rose et al., 1994; Conover et al., 
1993; Wolf et al., 1994; Yoshida et al., 1994). In this chapter, 
blastocysts are cultured in the presence of such factors with the aim of 
establishing germline-c ompetent ES cell lines. 
Materials and Methods 
Impl antati on -delayed blastocysts were flushed from mice of the 129 
OLA strain, homozygous for chinchilla (cchcch) 4 days after 
ovariectomy, which was performed on the third day of pregnancy. 
These embryos were then cultured as described in chapter 2. Medium 
was supplemented with either lOng/ml of DIA/LIF (murine, obtained 
by transfection of COS cells with), 500ng/ml of IL-6 and 5000ng/ml of 
sIL-6R (human; gift from T. Taga, Osaka), 50ng/ml OSM (human, 
Genzyme), or lOng/mi CNTF (rat, Genzyme). After 5 days, 
disaggregation was performed as described (chapter 2) and resultant ES 
cell colonies appearing in the cultures over the next 14 days were 
expanded and injected into blastocysts from C57B1/6 inbred mice. 
Chimaeras were tested for their ability to transmit ES cell-derived germ 
cells by test breeding with MF1 albino mice. The appearance of grey 
offspring implied successful germline transmission of the ES cell 
genotype, whereas agouti mice were indicative of procreation from the 
C57B1/6 host blastocyst. 
It' 
Results 
The frequency of isolation of ES cell lines de novo from blastocysts in 
culture is summarised in Table 1. Six ES cell lines were obtained from a 
total of 20 blastocysts cultured in medium supplemented with IL-6 and 
sIL-6R which exhibited the morphology and growth characteristic of 
previously derived ES cells (Nichols et al., 1990). In the absence of IL-6 
and sIL-6R such cells differentiate, but they can also be maintained in 
an undifferentiated state in the presence of DIA. Chromosome counts 
on each clone revealed a high proportion of cells exhibiting the normal 
number of 40 chromosomes. As summarised in table 2, all of these 
produced chimaeras following injection into host blastocysts, the 
chimaerism being extensive as judged by coat colour contribution (fig. 
5.1a and b), and comparing favourably with those produced by injection 
of one of the clones derived simultaneously in DIA. Germline 
transmission has been obtained from all of these clones (table 2). 
From 12 blastocysts cultured in medium supplemented with OSM, 
5 ES cell lines were derived (table 1). Each of these was injected into 
blastocysts and produced chimaeras with substantial coat colour 
contribution (fig. 5.1c). Test breeding proved 4 out of these 5 lines 
were able to pass through the germline (table 2). 
Using medium supplemented with CNTF, only one ES cell line was 
generated from 11 blastocysts. Several subsequent attempts were 
made following the first experiment in which a fresh batch of the 
cytokine was employed, and the concentration in the medium increased, 
but none of these produced stable ES cell lines The one established line 
gave rise to a single male chimaera when injected into blastocysts. 
Although by coat colour he appeared to possess an adequate 
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Table 5.1 A summary of the number of ES 	cell lines obtained 
using the cytokines 	interleukin-6 	(IL-6), oncostatin 	M (OSM), 
ciliary neurotrophic factor (CNTF) and differentiation inhibiting 




No. cell lines Factor 	 Source 	 Concentration 	 No. biastocysts 
IL-6+slL-6R Human 500+5000ngIml 20 
vi Human 5OngImI 12 
NTF Rat lOng/mi 11 
DIA/LIF Human lOng/mi 14 
6 
5 
contribution from the ES cells, he proved to be sterile, and was unable 
to transmit the ES cell genotype through his germline (fig. 5.1d). 
When transferred to the kidney or testis of a suitable recipient 
the embryonic ectoderm cells of the 6.5dpc egg cylinder proliferate to 
form teratocarcinomas (Stevens, 1970; Solter et aL, 1970), which can 
then be expanded in culture as embryonic carcinoma (EC) cells (Evans, 
1972). As part of this study, several attempts have been made to 
capture the pluripotential stem cells of early egg cylinders in culture 
directly. No success has been achieved, even using alternative 
cytokines, such as IL-6 with its soluble receptor, added to the culture 
medium. To date, all ES cell lines in use have been derived from either 
the 129 or the C57B1/6 strain of mouse. The ability to derive cell lines 
from other strains of mice may aid in the elucidation of the mechanism 
by which the stem cells are maintained in vivo. Attempts to derive ES 
cell lines from blastocysts of other strains have proved unsuccessful 
using DIA, or IL-6 +sIL-6R. The reason for this is unclear. It has been 
suggested that the variation in the rates of commitment and 
development for different strains of mice necessitates an alteration in 
the timing of the procedures used for the derivation of ES cells (A. 
Bradley, personal communication). However, using a range of time 
points for the disaggregation of cultured blastocysts of the CBA inbred 
strain, it has not yet been possible to derive ES cell lines (J. Nichols, 
unpublished). Alternatively, the propagation of stem cells from early 
embryos of the non-129 or C57B1I6 strains in vitro may require 
another factor, which acts alone or in combination with DIA. The nature 
of this possible alternative activity remains unknown. 
1 2 ? 
Table 5.2 Summary of the chimaeras obtained following injection 
into blastocysts of ES cells derived using the cytokines 
interleukin-6, differentiation inhibiting activity, oncostatin M or 
ciliary neurotrophic factor 
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I1-6A 27 9 8 	
(100) 
I1-6B 20 11 
8 	(87.5) 
11-6C 20 11 
5 	(60) 
11-6D 20 5 
3 	(0) 
11-6 E 20 9 
6 	(83.3) 
I1-6F 20 8 
4 	(25) 
DIA3 20 12 
4 	(50) 
OSM1 22 9 
7 	(57) 
OSM2 22 16 
10 	(60) 
OSM3 22 10 
1 	(0) 
OSM4 22 15 
5 	(100) 
CSM5 20 10 
4 	(25) 
















The generation of germline-transmitting chimaeras in medium 
supplemented with IL-6 + sIL-6R and OSM establishes that these 
cytokines can substitute for DIA in the derivation and maintenance of 
ES cells from mouse blastocysts. All of the ligands so far shown to 
inhibit ES cell differentiation require gp130 as a transmembrane 
component in their receptor complexes. IL-6 can associate with gpl30 
by means of a specific receptor component which lacks a 
transmembrane domain. This subunit is not expressed on ES cells (Saito 
et al.,1992), so must be added to the medium in soluble form, along 
with the IL-6 ligand, when applied to ES cells. In the case of IL-6, the 
maintenance of pluripotential ES cells apparently occurs without the 
involvement of the DIA-specific receptor subunit, since the IL-6-
specific receptor component induces homodimerisation of gpl30 
(Yoshida et al., 1994). The generation of 6 germline-competent ES cell 
lines from 20 blastocysts cultured in the presence of IL-6 + sIL-6R 
(table 1) indicates that the DIA-specific receptor component is not 
essential for the maintenance of stem cells in the 1CM, and that, in this 
context, signalling through gpl30 alone is sufficient. 
The number of ES cell lines derived from blastocysts cultured in 
medium supplemented with OSM (5 out of 12), and the proportion 
exhibiting transmission through the germline (4 out of 5) compares 
favourably with those derived in the presence of DIA (table 1). OSM 
has been found to bind with high affinity to the receptor complex 
utilised by DIA (Gearing et al., 1992), although it does also interact with 
another specific subunit (Gearing and Bruce, 1992; Liu et al., 1992). The 
inability so far to demonstrate the existence of a murine form of OSM 
1 *12 
Fig. 5.1 Chimaeric mice produced by injection of blastocysts with 
ES cells derived in medium supplemented with factors other than 
DIA 
a and b. 	Chimaeras produced with ES cells derived using 
oncostatin M (OSM) 
Example of a typical chimaera produced using ES cells derived 
in medium supplemented with interleukin-6 and the soluble form 
of its receptor (I1,6+sIL-6R) 
The single sterile male chimaera produced from ES cells 
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does, however, hinder further attempts to substantiate the suggestion 
that OSM may be involved in aspects of early mouse development. 
Only one ES cell line was obtained from the blastocysts grown in 
medium supplemented with CNTF, despite several repeated attempts to 
generate more. Why this is the case is not clear. Established ES cells 
can be inhibited from differentiation by the addition to the medium of 
CNTF (Conover et al., 1993). This may imply that they express the 
necessary receptor components for the action of CNTF. Preliminary 
analysis by RNase protection suggests that ES cells do express mRNA for 
the CNTF-specific receptor component, and that the level of expression 
increases as the ES cells differentiate (M. Robertson, unpublished). It is 
known that serum contains the soluble form of the CNTF-specific 
receptor component (Davis et al., 1993; Dittrich et al., 1994), and this 
may be utilised by the ES cells. The reason why the stem cells of 
blastocysts cannot be maintained in culture may be that the expression 
of the CNTF- specific receptor subunit becomes up-regulated during the 
establishment of ES cells. Alternatively, they may require a higher 
concentration of the soluble subunit than is present in the serum in the 
culture medium, or that they are unable to utilise it. The in situ 
hybridisation experiments described in chapter 4, in which the presence 
of CNTFR mRNA was sought in blastocysts, seem to suggest that there 
are very few, if any, CNTFR transcripts in the pluripotential 1CM cells. 
By 8.5dpc CNTFR autoradiographic grains are readily apparent in the 
developing neural tissue and neural crest, demonstrating that the probe 
binds specifically to tissues known to produce CNTFR (Ip et al., 1993). 
In situ hybridisation using the CNTFR probe on ES cells and blastocysts 
in parallel may help to establish whether there is a higher level of 
expression of CNTFR in ES cells. In spite of the apparent lack of CNTFR 
transcripts in the normal blastocyst, it is possible that expression of this 
receptor component is up-regulated in embryos which are unable to 
synthesise DIA, but which are viable. If this is the case, CNTF may be 
able to maintain stem cells in the early embryo when DIA is absent. In 
situ hybridisation to compare the expression of CNTFR in DIA-negative 
blastocysts with wild type embryos may provide some insight into this 
question. 
Since the outset of this work, null mutant mice for both IL-6 and 
CNTF have been produced by homologous recombination in ES cells (Poli 
et al., 1994; Kopf et al., 1994; Masu et al., 1993), and in neither case is 
the phenotype lethal in the homozygous condition. The removal of IL-6 
was reported to result in impairment of the immune and acute-phase 
response of adult animals when challenged with tissue damage or 
infection (Kopf et al., 1994), and to protection of female mice from the 
bone loss normally associated with depletion of oestrogen (Poli et al., 
1994). 	Absence of CNTF results in progressive atrophy of motor 
neurons in adult mice (Masu et al., 1993). 	While these data suggest 
that each of these cytokines is dispensible during early development, 
they may be able to fulfil the role of stem cell maintenance in the 
absence of an alternative mechanism. However, the involvement of an 




THE EFFECT OF ELEVATED LEVELS OF DIA ON THE DEVELOPING 
EMBRYO IN UTERO 
Introduction 
The expression patterns for the mRNAs of DIA and its receptor in the 
blastocyst suggest that DIA plays a role in early development (see 
chapter 3). The effect of DIA on the pluripotential cells of blastocysts 
in culture is to allow proliferation, resulting in the establishment of 
ES cell lines (Nichols et al., 1990; Pease et al., 1990). Alteration of the 
level and location of DIA expression in the developing embryo may, 
therefore, be expected to disrupt the stem cell pool. The availability 
of elevated concentrations of DIA over certain regions of the embryo 
may lead to an increase in the size of the stem cell population. The 
consequences of this for development cannot be predicted reliably in 
advance, but such phenomena as teratocarcinoma formation and the 
disruption of gastrulation may be anticipated. 
Administration of ectopic and additional DIA to the developing 
embryo by pronuclear injection of an over-expression vector at the 
one cell stage was not attempted for several reasons. Exposure of the 
embryo to elevated levels of DIA is predicted to cause disruption of 
development. The establishment of a stable transgenic line will not, 
therefore, be possible, and all investigations must be carried out on 
transgenic individuals generated de novo. Incorporation of the 
transgene after pronuclear injection is random. Of the embryos that 
survive the injection procedure, the DNA may fail to integrate in 
some and in others it may insert into a position from which it is not 
iO 
expressed. 	Random insertion into active genes will result in a 
variety of expression levels and timings for the onset and 
termination of transgene activity, dictated by the promoters of the 
interrupted genes. 	Any phenotypes obtained will, therefore, 
probably vary, making comparisons impossible to draw. 	Also, 
phenotypes obtained from a disruption within the genome may be 
complicated because of secondary gene expression effects. Allowing 
the developing embryonic cells to be exposed to external sources of 
the gene product avoids such complications. 
One method of presenting controllable quantities to the embryo 
is to use ES cells in which the required gene has been manipulated so 
as to alter the level and region of expression in the resulting 
differentiated products (Williams et al., 1988; Boulter et al., 1991; 
Wang et al., 1991). These ES cells can be characterised and the 
expression levels measured prior to injection into blastocysts, where 
they can, potentially, colonise all developing tissues (Robertson, 
1986), and the consequences observed in the resulting chimaeras. 
Various degrees of chimaerism may then provide a range of severity, 
so that a possible dosage effect of the gene product may be observed. 
If the ES cells are marked in some way, the effects of the availability 
of the gene product to different areas of the embryo can - be 
monitored. Thus, in principle, the use of ES cells as a means of 
delivering DIA to the developing embryo has several advantages. 
The level of the gene product available to the embryo can be 
controlled, to a certain extent, by the selection of an appropriate 
promoter and by the number of cells injected into each blastocyst, 
and the effects on specific regions of the embryo can be correlated 
with the different patterns of ES cell colonisation (Rashbass et al., 
1991). The effects of the diffusible form of DIA are unlikely to be 
cell-autonomous. Any phenotypes observed in chimaeras formed by 
injection of ES cells over-expressing the diffusible form of DIA, 
particularly those exhibiting small contributions from the ES cells, 
are likely, therefore, to be attributable to responses from the host 
cells, rather than to aberrant proliferation of the injected cells. 
To increase the amount of DIA available to the embryo, a 
construct was generated in which expression of the DIA gene is 
controlled by the murine PGK-1 promoter (Adra et al., 1987). This is 
considered to be a ubiquitous promotor, so the expression of DIA, 
and, hence, its potential action, will not be confined to particular 
parts of the embryo. The expression of genes driven by the PGK 
promoter is believed to proceed, regardless of the differentiative 
state of the cell. A continuous exposure of the tissues to DIA may, 
therefore, be achieved. Thus, a comprehensive screen for the effect 
of DIA on all developing tissues is potentially available. The 
manufacture of chimaeras using stably transfected cells should result 
in the ectopic production of DIA over a range of areas of the embryo 
and at varying levels, dictated by the ultimate position and number 
of donor cells. In this case, the injected cells carry a genetic variant 
of glucose phosphate isomerase (GPI) so that they can be 
distinguished from the host embryo. Chimaeras can be analysed at a 
selected time point during gestation by dissection, observation and 
isozyme electrophoresis to estimate the effects and level of 
contribution of the manipulated ES cells. 
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Materials and Methods 
The generation of constructs, transfection into ES cells and analysis of 
DIA RNA and protein production were all performed by Annette 
Düwel. Briefly, the plasmid giving rise to the results discussed in this 
chapter consisted of a 650bp fragment of human DIA cDNA under 
the control of the PGK promoter in pMC1 NEO poly A (fig. 6.1). The 
neo resistance gene is separated from the DIA gene by means of 
DHFR (dihydrofolate reductase), which has been found previously to 
improve the stability of the plasmid (Kaufman et al., 1989; Whyatt et 
al., 1993). Two clones which produced elevated levels of DIA were 
selected for injection into blastocysts. Blastocyst injection was 
performed as described in chapter 2, and the resulting conceptuses 
analysed at 8.5 or 9.5dpc. Abnormalities were assessed by 
examination under a dissecting microscope. Levels of chimaerism 
were estimated by GPI electrophoresis, as described in chapter 2. 
Using this technique, embryos can be divided into small pieces to test 
for chimaerism in a tissue-specific manner, but precise in situ 
localisation is not possible. 
PLI 
Fig. 6.1 Diagrammatic representation of the plasmid used for the 
production of ES cells over-expressing DIA 
PGK=promoter for the phosphoglycerate kinase gene 
hDIA=human differentiation inhibiting activity 
DHFR= murine dihydrofolate reductase gene 
TK promoter=promoter for the thymidine kinase gene 
NEO=Neomycin phosphotransferase (to confer resistance to the 











Two clones, Dl and D7, were selected which produced significant 
amounts of DIA in both differentiated and undifferentiated ES cells. 
This elevation in the production of DIA is known to originate from 
the transgene, since the DIA cDNA used for the construct is derived 
from the human gene. This can be distinguished from the murine 
form by means of antibodies. Both clones behaved in culture in a 
manner reminiscent of the parent cell line. Upon removal of DIA 
from the culture medium, they both underwent differentiation into 
flattened, fibroblast-like cells, typical of those seen following 
withdrawal of DIA from the medium of other ES cells. This suggests 
that, following injection into blastocysts, these cells will be able to 
differentiate and contribute to developing tissues. Inability to 
differentiate and integrate with the host embryonic tissues may 
result in the formation of teratocarcinomas from the injected cells, 
the effects of which cannot be attributed purely to a response of the 
host embryo to the elevated amounts of DIA. Confirmation that 
differentiation had occured in the transfected clones was provided 
by the absence of alkaline phosphatase staining in the cells which 
had been grown at low density in the absence of DIA for several 
days, whereas those which had been constantly in the presence of 
DIA exhibited staining characteristic of undifferentiated ES cells. 
However, both lines were inclined to maintain foci of stem cells more 
abundant than those observed with the parent cell line when grown 
at high density and in the absence of exogenous DIA. 
I ILJL 
Control injections were performed using ES cells of the parental 
cell line EFC, which had not been transfected with the over-
expression construct. The only abnormalities observed in the 
embryos dissected following injection of the control cells were 
retardation or resorption (Table 1). The numbers of abnormal 
embryos obtained from each experiment performed using Dl 
compared with control injections are summarised on table 2. Various 
abnormalities could be seen in embryos injected with the clone 
producing the most DIA (Dl) when they were dissected at 8.5 or 
9.5dpc. Some of the same phenotypes were observed using D7. The 
results obtained using D7 are probably not so severe because this 
line produces less DIA than does Dl. The phenotypes observed using 
both lines are categorised in Table 1. The most commonly observed 
abnormality is described in the table as 'disorganised'. These 
structures were contained within comparatively small decidua and 
bore apparently normal ectoplacental cones. Each was surrounded 
by Reichert's membrane, but other tissues were not easy to 
distinguish. They tended to be multi-lobed structures, each lobe 
consisting of two layers, superficially reminiscent of the primitive 
ectoderm and visceral endoderm of an early egg cylinder (figs. 6.2b, 
6.4a). The second most abundant manifestation was the appearance 
of many uniform small protuberances (blebs) in the visceral yolk sac 
(VYS; fig. 6.2c and d). Apart from this, the embryo generally looked 
normal. Several embryos were obtained in which the body axis had 
been duplicated, but both axes were within the same visceral yolk 
sac (fig. 6.4b). Another deformation could sometimes be seen in the 
head region. The two neural folds tended to gape open and either or 
II.c 
Fig. 6.2 	Embryos dissected at 8.5dpc following injection of Dl ES 
cells into 	blastocysts 	(photographs taken 	using 	an Olympus 
dissecting microscope) 
A morphologically normal 8.5dpc embryo. EPC=ectoplacental 
cone, VYS=visceral yolk sac 
A 'disorganised' conceptus consisting of an apparently normal 
ectoplacental cone (EPC) and parietal yolk sac (PYS), but having 
multiple lobes in the place of the embryonic structure 
c and d. 	Conceptuses exhibiting fairly normal embryonic structure 











both were distorted (figs. 6.3a and b, 6.4c and d). 	Additional 
outgrowths resembling allantoises were seen in a significant number 
of cases (fig. 6.3a). The region in the embryo from which these 
protruded was not constant. Slightly less commonly, the definitive 
allantois was deformed (figs. 6.3a and b, 6.4c and d), being large, 
spherical and vascularised. A couple of specimens exhibited 
additional extra-embryonic membranes, which resembled amnions 
or yolk sacs. The least frequently observed phenotype was a kinking 
of the body axis (fig. 6.3b). In both examples, the phenomenon was 
accompanied by an abnormal allantois, suggesting that the deformity 
may have been brought about by mechanical distortion as the 
embryo attempted to turn. 
Several embryos exhibited more than one of the abnormalities 
listed in the table; consequently, the total number of implantation 
sites is lower than the sum of the listed phenotypes. The level of 
chimaerism was investigated in many of the conceptuses by GPI 
electrophoresis (table 3). The estimated percentage of the tissue 
exhibiting the donor ES cell form of the enzyme (GPI laa) was 
classified as more than 40%, between 5 and 40%, or undetectable. 
GPI values are not available for all of the specimens studied; some 
were reserved for wholemount in situ hybridisation using a probe 
for human DIA, but no specific signal above background could be 
detected. 
w 
Fig. 6.3 	Abnormal embryos produced from blastocysts injected 
with Dl ES cells dissected at 8.5dpc (photographed using an 
Olympus dissecting microscope) 
An embryo showing an abnormal head structure and allantois, 
and an additional outgrowth from the anterior region resembling 
an allantois 
An embryo exhibiting an abnormal head and allantois and a 










A study was previously published in which chimaeras have been 
made from ES cells over-expressing either the diffusible (D-DIA) or 
matrix-associated (M-DIA) form of DIA (Conquet et al., 1992). 
According to that report, and in contrast to the results described 
here, no effect was seen when embryos were exposed to high levels 
of D-DIA, whereas the use of M-DIA produced abnormalities 
proportional to the level of chimaerism. The interpretation of these 
results by the authors is that elevated levels of the diffusible form of 
DIA do not affect the early development of mouse embryos, whereas 
an increase in the exposure of the embryo to the matrix-associated 
form of DIA results in the inhibition of gastrulation and abnormal 
proliferation of the embryonic ectoderm. No mesodermal structures 
could be discerned by histological analysis, and in situ hybridisation 
using a probe for the mesodermal marker Brachyury could not detect 
any specific expression. Alternatively, these abnormalities in high 
level chimaeras may actually reflect a restriction in the ability of the 
injected cells to differentiate. Indeed, no evidence is presented that 
these cells were even capable of differentiation; clones over-
expressing DIA which were to be used for the injections were grown 
in the absence of feeder cells or exogenous DIA, and failed to 
differentiate in vivo, even after several passages. Chimaeras 
obtained following injection of the M-DIA over-expressing cells were 
reported to exhibit an abnormal phenotype when the level of 
chimaerism, as estimated by GPI electrophoresis, was above 50%. 
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Fig. 6.4 Abnormal struct:ires generated by inje; tion of DI ES cells 
into blastocysts discected at 85dpc 
A disorganised rnup1e-iohed structure 
EPC=ectoplacental cone 
 An embryo exhibiting a duplication of the body axis, such that 
two tail buds and a double head can be seen in the photograph 
VYS=visceral yolk sac 
C. 	An embryo showing 	deformities 	in 	the allantois and head 
region, including an 	additional 	outgrowth from 	the extreme 
anterior 
VYS=visceral yolk sac 
Al=allantois 
Am= amn ion 
H=head fold 
d. An embryo showing an abnormal allantois and head region 
_ 
1.I 
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Few host cells were, therefore, available in the developing foetus to 
respond to the effects of the injected cells. These abnormal embryos 
were composed of two layers, morphologically resembling an 
epithelium and visceral endoderm. No mesodermal tissues could be 
detected. Consistent with the argument that the phenotypes 
obtained resulted from abnormal growth of the injected cells rather 
than from an effect of excessive DIA on the developing embryo, such 
abnormalities were not obtained when ES cells over-expressing D-
DIA were injected. The matrix-bound form of DIA is less likely to be 
available to parts of the embryo which are physically separate from 
the injected cells than is the diffusible form. Chimaeras were made 
by injection into host embryos at the morula stage. The use of this 
technique was previously shown to result in a significant number of 
abnormal embryos, even when putative normal ES cells were used 
(Lallemand and Brulet, 1990). The study by Conquet et al., (1992) 
may not, therefore, represent true effects of DIA on the cells of the 
developing embryo. 
The findings documented here demonstrate that injection into 
blastocysts of ES cells expressing abnormally high levels of the 
diffusible form of DIA can perturb the development of the embryo. 
Chimaeras generated by injection of the parental cell line did not 
produce abnormalities, other than a few retarded or resorbed 
foetuses. The phenotype and degree of abnormality obtained from 
injection of the cells over-expressing DIA varied, although not in 
strict proportion to the level of chimaerism. However, they could be 
grouped into categories which were specific, and have rarely been 
encountered previously. The most commonly observed abnormality 
Table 6.1 Summary of, the abnormalities observed in embryos 
obtained following injection into blastocysts of ES cells over-
expressing DIA (Dl and D7) compared with control ES cells 
Table 6.1 
INCIDENCE 
EFC(control) 	 Dl 	 D7 
o 	 26 	 0 
o 15 0 
structure 	 o 	 8 	 0 
o 7 4 
o 	 8 	 4 
o 8 0 
o 	 2 	 0 
0 2 4 
4 	 5 	 7 
1 9 2 
67 	 75 	 37 
ABNORMALITY 
Diso rgan ised 










was the disorganised, multi-lobed structure (figs. 6.2b, 6.4a). As far 
as could be seen by gross observation without sectioning, each lobe 
seemed to be composed of two layers of cells similar to the primitive 
ectoderm and visceral endoderm of an early egg cylinder. One of the 
anticipated effects of excess DIA on the stem cells in such a system is 
the prolonged preservation of the undifferentiated state. The 
resultant larger pool of stem cells might be expected to give rise to a 
giant egg cylinder. Such a structure was never seen in these 
experiments. However, the disorganised phenotype described as the 
most commonly observed abnormality may be imagined to resemble 
a collection of egg cylinders, which may be the result of 
differentiation from several foci. No histology was performed on 
these structures to investigate this idea, since they had to be 
disrupted for GPI analysis. Gastrulation in the mouse embryo is 
thought to occur when the egg cylinder attains a specific size (P. Tam, 
unpublished). If this is the case, the putative multiple egg cylinders 
obtained here may represent the outcome from an enlarged stem cell 
pooi caused by the presence in the embryo of elevated levels of 
DIA. 
Embryos were also obtained which exhibited multiple axes 
with recognisable body structures (fig. 6.4b). Most of the members 
of this category were twins, but some embryos with three axes were 
also observed. These may represent an alternative form of the 
multiple egg cylinders described above, in which the individual axes 
were able to attain a more advanced developmental state. 
On several occasions, individuals with structures protruding 
from various parts of the embryo, superficially resembling 
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Table 6.2 Summary of the number of abnormal embryos obtained 
from each experiment of injection into blastocysts of ES cells over-
expressing DIA (Dl) compared with control ES cells (EFC) 
Table 6.2 
EXPRT INJECTED IMPLANTED NORMAL RETARDED RESORBED ABNORMAL 
1 24 19 10 2 4 3 
2 41 28 10 1 3 14 
3 7 7 4 1 0 2 
4 10 8 5 0 0 3 
5 12 5 3 0 0 2 
6 26 13 2 1 0 10 
7 19 19 11 0 0 8 
8 46 42 26 7 0 9 
TOTAL(D1) 185 141 71 12 7 51(36%) 
cONTROL(EFC) 125 85 74 5 2 4(5%) 
supernumerary allantoises were observed (fig. 6.3a). 	In normal 
development, the remaining core of stem cells (the primitive streak) 
is restricted to the posterior region of the developing foetus at the 
time of the appearance of the allantois. The allantois is derived at 
gastrulation from the cells which migrate posteriorly from the 
primitive streak as the extra-embryonic mesoderm. The persistence 
of stem cells in ectopic positions along the embryo caused by local 
synthesis of DIA may result in the ectopic differentiation of 
extraembryonic mesoderm, and subsequent outgrowth of a 
supernumery allantois. Alternatively, it may represent an undefined 
overgrowth of stem cells. If this is the case, this category may be 
considered to have arisen in much the same way as the disorganised 
and duplicated axis classes. It is not possible to distinguish between 
these derivations purely from morphology. 
Another phenotype observed occasionally was a comparatively 
normal embryo with a large, bulbous and generally vascularised 
allantois (figs. 6.3a and b, 6.4c and d). On two occasions the trunk 
region of the embryo, particularly the neural tube, was kinked. This 
probably represents mechanical distortion due to obstruction by the 
inflated allantois rather than a direct effect of the injected cells upon 
the body axis. Why the allantois should grow in such a way is not 
clear, but it could be a result of a proliferative signal coming from 
the regional elevation in the concentration of DIA arising from the 
injected cells. However, the phenomenon of such a deformed 
allantois has been observed previously in chimaeras made using high 
passage number ES cells of the parental line (data not shown), which 
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Table 6.3 	Summary of the levels of chimaerism by glucose 
phosphate isomerase analysis (GPI) observed in the normal and 
abnormal embryos obtained following injection into blastocysts of 
ES cells over-expressing DIA (EFC Dl) 
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Table 6.3 
Cell 	line Phenotype Total Level of chlmaerlsm 
>40% 5-40% Undetectable 
EFCD1 Normal 75 5 16 26 
EFC (control) 
a 
67 21 19 21 
EFCD1 Disorg nised 26 1 9 8 
• BlebbyVYS 15 2 4 5 
Retarded 9 1 4 4 
EFC (control) 1 1 0 0 1 
EFC Dl Duplicated axis 8 1 3 0 
• Abnormal head 8 1 4 0 
• Extra 	'allantois' 8 2 3 0 
• Resorbed 5 
EFC (control) 2 4 
EEC Dl Extra membrane 2 0 1 1 
• Kinked 2 1 1 0 
Total number of Implantations 
EFCD1 	 149 
EFC (control) 	 72 
The levels of chimaerism were compared between mild and 
severe abnormalities for Dl abnormal embryos using x2  analysis. 
Comparing all three columns (>40%, 5-40% and undetectable 
chimaerism; 7:17:10 (mild) versus 2:12: (severe)), 2 =1.35 2df 
P=0.51. This suggests that there is no significant difference in the 
level of chimaerism between the mildly and severely abnormal 
groups of embryos. 
Comparing detectable versus undetectable chimaerism in 
the mild versus severe categories (24:10 versus 14:18), 2 =0.296 
P=0.59, confirming the previous observation. 
High level (>40%) chimaeras were compared with low level 
(5-40%) chimaeras in the mild versus severe categories of Dl 
embryos (7:17 versus 2:12). Using Fisher's exact test, no 
significant difference was detected. 
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suggests that it may not be an effect specific to the over- expression 
of DIA. 
Some embryos appeared normal, apart from a distribution of 
blebs on the visceral yolk sac (fig. 6.2c and d). These may be a result 
of slight over-growth of the visceral endoderm or mesoderm during 
development, or they may represent undifferentiated stern cells 
which have been trapped inside the yolk sac. Without the option of 
being able to perform histology on these specimens such alternatives 
cannot be distinguished. The abnormal heads occasionally obtained 
are also difficult to explain (figs. 6.3a and b, 6.4c and d). The cells of. 
the neural plate are likely to be responsive to DIA, since significant 
levels of DIA-R IIiRNA have been detected in this tissue (see chapter 
3). Failure of the neural tube in the anterior region to close properly 
could be caused mechanically by a thickening of the tissue in that 
region, caused by over-proliferation of the cells, which would 
provide resistance against the curvature required for tube formation. 
Alternatively, there may have been some reduction in the adhesive 
nature of the neural folds which normally holds them together once 
they have become associated. 
The fact that some of the embryos exhibiting gross 
abnormalities had an almost negligible contribution from the injected 
ES cells (table 3) raises some concern that the phenotypes observed 
in this experiment are, in fact, an artifact of the manipulation. 
However, some relatively high level chimaeras appeared to be 
unaffected, and the control injections did not generate these 
abnormalities. Both of the experimental cell lines produced similar 
abnormal phenotypes, although those arising from the injections 
using D7 were notably less severe. This is probably a reflection of 
the reduced expression of DIA by D7 when compared with Dl. 
The degree of abnormality does not correlate well with the 
level of chimaerism. There may be several explanations for this. 
Firstly, a contribution of less than 5% from the donor cells is not 
clearly discernable by GPI electrophoresis, so the abnormal embryos 
in which no contribution from the ES cells has been recorded may be 
bona fida chimaeras, but of a level beneath detection; Secondly, the 
injected over-expressing cells may be selected against during 
development so that they are removed to a large extent after they 
have initiated an effect, and consequently are not detected by GPI 
electrophoresis on the embryos when they reach the equivalent of 
8.5 or 9.5 days of development. The abnormalities obtained in some 
conceptuses may depend on the injected cells occupying a critical 
position in the embryo. In the low or negligible level chimaeras 
exhibiting abnormalities, the host embryo cells must be responding 
to the injection, since their is an insufficient contribution from the 
injected cells to explain the gross phenotype obtained. The 
abnormalities seen are not, therefore, caused merely by 
inappropriate proliferation of the injected cells (table 1). 
The fact that some of the normal embryos exhibit significant 
chimaerism suggests that the injected cells are not producing enough 
DIA to affect the embryo detrimentally in these instances. This may 
result from the transgene becoming inactive, either globally or in 
some of the donor cells of these apparently unaffected embryos. 
To distinguish between these possible explanations attempts 
have been made in collaboration with Annette Düwel to detect over- 
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expressing cells by means of wholemount in situ hybridisation using 
a digoxygenin-labelled probe for DIA. The wholemount in situ 
hybridisation technique proved to be insufficiently sensitive to 
detect the increased expression of DIA above background. Certainly, 
by this method, it would be impossible to detect at a cellular level a 
slight increase in the amount of DIA mRNA which may be 
responsible for the abnormalities obtained in the experiment. 
Consequently, it has not been possible to map the critical positions at 
which DIA may act to influence the maintenance of stem cells in the 
developing embryo. 
An alternative approach also adopted was to try to produce 
chimaeras using cells over-expressing DIA but also carrying the Lac Z 
gene as an in situ marker for the injected cells. The Lac Z gene in 
association with neomycin-resistance was incorporated into the 
plasmid together with DIA and the picornaviral internal ribosome-
entry site (IRES), which enables cap-independant translation of Lac Z 
from a fusion transcript. Thus, the production of DIA from 
successfully transfected ES cells should be accompanied by 
expression of 5 gal, which can be visualised by staining with X-gal 
(see chapter 2). Different intensities of staining should reflect 
different levels of production of DIA. Unfortunately, upon removal 
of the stably transfected ES cells from selection with 0418, the level 
of production of DIA decreased. Presumably, the DIA activity had 
diminished when these cells were injected into blastocysts so that 
only morphologically normal embryos were recovered. Some of 
these were highly chimaeric, as estimated by the degree of staining. 
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The range of phenotypes which have been reported in this 
chapter, and the low level of contribution by injected ES cells to some 
of the very abnormal embryos provides strong evidence that DIA is 
able to influence the development of the host cells in the early 
embryo and elicit specific responses which may be attributable to 
increases in the stem cell pool. Clearly, the exposure of certain early 
embryonic cells to increased levels of DIA does influence the 
subsequent development of the embryo, and the effects seen here 




In the mammalian embryo the pluripotential cells become 
progressively committed to specific lineages. Cell division is not 
synchronous and the cell cycle times vary. There is much 
flexibility in the system at the early stages; removal or ablation of 
large proportions of the embryo up to the egg cylinder stage can 
be overcome by the recruitment of other cells from the existing 
stem cell pools, resulting in normal embryogenesis (Snow and 
Tam, 1979). The absence of rigid pre-determination of the 
specific tissues in the early mouse embryo, and the ability of the 
embryo to regulate its overall size and the proportions of the 
component cell types necessitates a mechanism for modification. 
Factors produced by the constitutive cells may be envisaged as a 
means of signal; the output from a particular cell type may be 
required to reach a threshold level before an inhibitory 
mechanism is brought into play to restrict the ultimate size of the 
tissue. Cytokines and their receptors are probably involved in the 
operation of such a regulatory system. 
When removed from the in vivo environment the cells in 
the early embryo tend to differentiate in the absence of any 
exogenous stem cell maintenance factor. The investigation of the 
action and distribution of candidate molecules for the prevention 
of differentiation of the stem cells in the early embryo has been 
the subject of this study. The questions addressed have included 
the ability of the stem cells in the early embryo to respond to 
candidate molecules in culture, the availability of such molecules 
to the embryo in vivo, and the response of early embryonic cells 
in developing embryos to exposure to elevated levels of one of 
these molecules. 
The first candidate molecule for the maintenance of the 
stem cells in the early embryo is the cytokine differentiation 
inhibitory activity (DIA). This was selected because of its ability 
to inhibit the differentiation of ES cells in culture (Smith et al., 
1990). The data presented in this study are consistent with the 
suggestion that DIA plays a role in the preservation of the 
pluripotential stem cell pooi in the early murine embryo. 
The extra-embryonic regions of early egg cylinders have 
been shown previously, by RNase protection, to express DIA 
mRNA (Rathjen et al.,1990b). Using in situ hybridisation it has not 
been possible consistently to detect transcripts for DIA in egg 
cylinders after 6dpc. This is almost certainly because of the 
decrease in sensitivity of the in situ hybridisation technique 
compared with RNase protection. The in situ data, however, 
indicate that there is a down-regulation in the expression of DIA 
after the blastocyst stage. In later embryogenesis and post-
natally, transcription is detectable in certain tissues, generally at 
very low levels (Robertson et al., 1993). 
In situ hybridisation has been used here to demonstrate 
that transcripts for DIA mRNA are restricted to the first cells to 
differentiate in the preimplantation embryo, namely the 
trophectoderm (fig. 3.3a). The undifferentiated cells of the inner 
cell mass (1CM), which are the anticipated target for DIA in this 
context, have been shown to express the components of the DIA 
receptor. The DIA-specific subunit appears to be restricted to the 
1CM (fig. 3.3b), while gpl30, the signal transducing subunit, which 
is also a component of the receptor complexes of several other 
cytokines, is expressed predominantly in the 1CM, but transcripts 
are also apparent in the trophectoderm (fig. 3.3c). Thus, a 
paracrine interaction is implied between the trophectoderm and 
the 1CM, where the differentiated cells secrete DIA, which binds to 
the high affinity receptors located on the surface of the cells of the 
1CM, protecting them from precocious differentiation. 
Although transcripts for DIA mRNA have been detected by 
RNase protection analysis in the extra-embryonic region of the egg 
cylinder (Rathjen et al., 1990b), they are not evident by in situ 
hybridisation (chapter 3). Unequivocal expression of DIA is seen. 
by this method in blastocysts. This implies a decrease in the level 
of transcription of DIA as the embryo approaches and undergoes 
gastrulation. Indeed, by RNase protection there is a distinct 
decrease in the detectable expression of DIA in embryos from 6.5 
to 7.5dpc (Rathjen et al., 1990b). Administration of elevated 
levels of DIA to developing embryos can lead to the formation of 
multiple-lobed ('disorganised') structures or duplications of the 
body axis (chapter 6). It is envisaged that the multiple lobed 
structures may be composed of several egg cylinders. If this is 
the case, a role for DIA in the regulation of the size of the embryo 
and the timing of egg cylinder formation is implied. The down-
regulation of DIA mRNA expression in the embryo following 
implantation may be important for restriction in the size of the 
stem cell pool. 
As seen by in situ hybndisation, the level of DIA receptor 
mRNA is lower in egg cylinders compared with ICMs, which 
suggests that the receptor becomes down-regulated prior to the 
onset of overt differentiation in the embryonic ectoderm (chapter 
3). This is possibly connected with the reduction of DIA mRNA 
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expression over the same period, and may also be involved in the 
reduction in the pluripotentiality of the stem cell pool prior to 
gas trul ati on. 
By 8.5dpc significant expression of DIA-R mRNA is re-
activated in most tissues of the embryo (figs. 3.8a and c, 3.9a and 
c). This may be because DIA-R contributes to the receptors for 
other cytokines, such as ciliary neurotrophic factor (CNTF), which 
is thought to be involved in neuronal development (Ip et al., 
1993). The expression of gp130 mRNA in egg cylinders is 
detectable, but significantly lower than in the surrounding 
decidual tissue (figs. 3.8b and d, 3.9b and d, 3.10). As with DIA-R 
mRNA, the level of gpl30 mRNA increases in embryonic tissues at 
8.5dpc (fig. 3.11). 
In the decidual tissue surrounding the embryo following 
implantation transcripts for DIA-R and gpl30 mRNA are abundant 
(figs. 3.8 and 3.9). By 8.5dpc the levels of DIA-R have decreased 
significantly, whereas the expression of gpl30 has undergone a 
significant increase. The reason for this reciprocal regulation of 
expression is not understood. There are several possible 
explanations for the production of the components of the DIA 
receptor in the deciduum of the early postimplantation embryo. 
The adult tissue in which the highest levels of DIA expression 
have been detected is the uterus (Robertson et al., 1993). During 
all the stages of pregnancy studied here, relatively abundant 
transcripts have been localised to the endometrial glands. The 
function of these glands is not known, but they may be involved 
in implantation. The inability of female homozygous null mutants 
for DIA to support implantation is consistent with such a role for 
these glands to which the DIA mRNA in the uterus has been 
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localised (Smith et aL, 1992; Stewart et aL, 1992; chapter 3). Also, 
the level of expression of DIA mRNA in the uterus is reported to 
undergo a dramatic increase just before implantation (Bhatt et al., 
1992). Transcripts for the diffusible form of DIA have been 
detected in the pregnant uterus (Robertson et al., 1993; chapter 
3), suggesting that. DIA may be secreted into the uterine lumen. 
In addition to the decidual expression, both DIA-R and gpl30 
mRNA are present in the endometrial glands. The DIA receptor 
probably, therefore, binds the secreted DIA, but whether the 
purpose of this interaction is to present the DIA to the developing 
embryo, or to immobilise it in the deciduum is not clear. As 
demonstrated in chapter 6 and reported by Conquet et al., (1992), 
exposure of the embryo to elevated levels of DIA is detrimental to 
development. Fine control to ensure that an appropriate amount 
of DIA is available to the developing embryo is likely to be 
important. Therefore, the function of the DIA receptor in the 
deciduum may be to protect the developing embryo from the DIA 
being secreted by the endometrial glands. 
At the outset of this study, nothing was known about the 
phenotype of embryos lacking DIA. Subsequently, several groups 
have created null mutations (Stewart et al., 1992; Escary et al., 
1993; Smith et al., unpublished). In these studies females lacking 
DIA are unable to support implantation, but homozygous null 
blastocysts can implant and undergo normal development if 
transferred to the uterus of a wild type or heterozygous foster 
mother. This result indicates that DIA is not indispensable for the 
protection of undifferentiated stem cells in the early embryo. The 
DIA mRNA detected in the uterus has been shown by in situ 
hybridisation to localise to the endometria! glands (chapter 3; 
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Bhatt et al., 1992; Smith et al., 1992). 	The inability of null 
mothers to support implantation implies a role for these glands in 
this process. However, endometrial glands are present in null 
mothers several days alter fertilisation (fig. 7.2). Embryos flushed 
from homozygous DIA-negative mothers at 6.5dpc closely 
resemble the blastocysts from wild type mice which have been 
held in delayed implantation for several days, both 
morphologically (fig. 7.1), and in their behaviour in culture. Null 
embryos are able to attach to the surface of a tissue culture plate 
and grow in a manner indistinguishable from that of wild type 
delayed blastocysts (fig. 7.1). This provides evidence that the 
inability of embryos to implant in a null mother is unlikely to 
result from an inadequacy in the invasive potential of the 
trophectoderm of the null blastocyst, and strengthens the case for 
the involvement of DIA in preparing the uterus for implantation. 
It also implies that the blastocyst itself does not need DIA, either 
embryonic or maternal. 
Recently, characterisation of the high affinity DIA receptor 
has identified a signal transducing subunit, gpl30, which was 
initially discovered as a component of the receptor for 
interleukin-6 (IL-6; Taga et al., 1989; Hibi et al., 1990). Ciliary 
neurotrophic factor (CNTF) and oncostatin M (OSM) are now 
known also to operate via receptors that utilise gpl30 (Gearing 
and Bruce, 1992; Gearing et al., 1992; Ip et al., 1992; Murakami et 
al., 1991). The ability of these cytokines to mimic the effect of 
DIA in the context of differentiation inhibition, in pluripotential 
stem cells has been tested by addition of each to the culture 
medium for ES cells in the place of DIA (Yoshida et al., 1994; 
Conover et al., 1993; Wolf et al., 1994; Rose et al., 1994). Because 
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Fig. 7.1 A comparison of embryos homozygous for the absence of 
DIA flushed from null mothers at 7.5dpc (left hand side) with 
wild-type implantation-delayed embryos flushed from mothers 4 
days after ovariectomy (right hand side) 
Photographs taken using a x20 objective on an Olympus IMT2 
microscope 
a and b. Embryos immediately after flushing 
ICM=inner cell mass 
TE=trophectoderm 
c and d. Embryos attaching to the tissue culture dish 2 days after 
flushing 
e to h. Embryos having been allowed to attach and outgrow in 
culture for 5 to 6 days 












































































ES cells are known not to express the IL-6-specific receptor 
component (sIL-6R; Saito et al., 1992), a soluble form of this is 
required in addition to the IL-6 ligand. In each case, the 
alternative cytokine has been shown to inhibit the differentiation 
of ES cells in culture in a manner indistinguishable from that 
achieved using DIA. Following injection into blastocysts, the lines 
maintained for several generations in the presence of each 
cytokine have been able to contribute to the germline of resulting 
chimaeras. 
Results presented here have demonstrated that CNTF, OSM 
and IL-6+sIL-6R are able to act directly on the pluripotential stem 
cells of the 1CM, resulting in generation de novo of pluripotential 
ES cell lines (chapter 5). The proportion of blastocysts giving rise 
to germline-competent ES cells in the presence of OSM or IL-
6+sIL-6R is comparable to the efficiency achieved with DIA in this 
context. The number of ES cell lines generated using CNTF was 
very low, and no germline transmission has yet occured. It is 
possible that the CNTF-specific receptor component is not 
sufficiently abundant in the 1CM for efficient response to the CNTF 
ligand. The in situ hybridisation studies described in chapter 4 
using a probe directed at CNTFR suggest that there is little or no 
expression of the gene in the mouse blastocyst. A soluble form of 
CNTFR is present in serum (Davis et al., 1993; Dittrich et al., 1994). 
This may be utilised by established ES cells, whereas the cells of 
the 1CM may be less well able to harness the component from 
serum. Preliminary results using RNase protection analysis 
suggest that ES cells do produce transcripts of mRNA for CNTFR, 
the level of expression increasing as the ES cells undergo 
differentiation (M. Robertson, unpublished). In the embryo 
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Fig. 7.2 Section through the uterus of a female mouse homozygous 
for the absence of DIA 7.5dpc stained with methyl green to show 







detectable levels of CNTFR are seen by in situ hybridisation in the 
neural tube and neural crest at 8.5dpc, representing a significant 
increase of expression accompanying differentiation in vivo 
(chapter 4). 
The in situ hybridisation data for CNTF, CNTFR and IL-6 
reported in chapter 4 suggest that the mRNA for neither of these 
cytokine systems is being produced by the blastocyst in detectable 
quantities. As discussed in chapter 4, investigation of the 
expression of OSM in the mouse embryo is not yet possible. The 
ability of OSM to operate via the DIA receptor (Gearing et al, 1992), 
suggests that this cytokine may be the most likely substitute for 
DIA. 
IL-6 and CNTF have been removed from mice 
independently by means of homologous recombination in ES cells 
(Kopf et al., 1994; Poli et al., 1994; Masu et al., 1993). Although in 
each case specific effects were reported, the phenotypes became 
apparent only when the homozygous mutants reached adulthood. 
Neither of these cytokines is, therefore, essential for development 
of the early embryo. Double mutants were created by crossing 
CNTF null mice with DIA null mice. In these animals the 
characteristics observed in CNTF-I- individuals were exascerbated, 
but they were able to reach adulthood (Sendtner et al., in 
preparation). The generation of complex mutants lacking functional 
genes for all the cytokines which utilise the gpl30 signal 
transduction pathway may be a means to determine whether this is 
the only pathway involved in the maintenance of the stem cells in 
the early mouse embryo. However, targeting experiments for the 
receptor components may be more informative. 
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Recently, other cytokines, such as IL-li have been found 
to bind to receptors which utilise gpl30. However, the existence 
of an alternative signal transduction pathway for this purpose is 
now being considered. The generation of mice lacking the DIA 
receptor has recently been achieved (Meng Li, in preparation). 
Homozygous null individuals are apparently able to undergo 
embryogenesis. This strongly implies that an alternative route to 
the DIA receptor complex is available for stem cell preservation in 
early embryos. Research in progress suggests that removal of 
gpl30 from mice results in a phenotype that is lethal in the 
homozygous condition, but not until the later stages of gestation 
(Taga et al., in preparation). If such individuals are genuinely 
devoid of gpl30, an alternative signal transduction pathway for 
the suppression of differentiation in the early embryo must exist. 
Until such a pathway has been identified, characterised and 
ablated it is not possible to ascertain which system is likely to be 
the predominant controller of stem cell regulation. If inhibition of 
the putative alternative system results in lethality at an early 
embryonic stage, it must be assumed that the DIA system is 
dispensible for early embryonic events other than implantation. 
Differentiated ES cells in which both DIA alleles have been 
removed by homologous recombination have been found to 
produce a factor which can inhibit the differentiation of normal 
established ES cells in culture (C. Dani et al., in preparation). The 
identity of this factor, and its mode of operation have yet to be 
determined. However, it has been found to be active in the 
presence of blocking antibodies against gpi 30. 
The removal of each of the components of the DIA system 
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